Check out the online TTS 2024 Program

Time	Room	Session
07:00-08:00	21	21 07:00 Invited Symposia: Game Changers in Alloimmune Risk Stratification Full Details Rainer Oberbauer, Austria Genome-Wide Non-HLA vs HLA Alloimmunity Rainer Oberbauer, Austria Genome-Wide Non-HLA vs HLA Alloimmunity Fadi Issa, United Kingdom Spatial Phenotyping of Immune Cells in Tolerance Versus Rejection Fadi Issa, United Kingdom Spatial Phenotyping of Immune Cells in Tolerance Versus Rejection Aravind Cherukuri, United States The Impact of Innate Allorecognition Aravind Cherukuri, United States The Impact of Innate Allorecognition
07:00-08:00	155	155 07:00 Invited Symposia: HIV and Transplantation: A Global Perspective on Milestones Achieved and Milestones Ahead Full Details Elmi Muller, South Africa From Breakthroughs to Benchmarks: A Global History of HIV and Transplant Elmi Muller, South Africa From Breakthroughs to Benchmarks: A Global History of HIV and Transplant Vagish Hemmige, United States Beyond the Horizon: Pioneering Thoracic and Living Donor Transplants for HIV+ Individuals Vagish Hemmige, United States Beyond the Horizon: Pioneering Thoracic and Living Donor Transplants for HIV+ Individuals Christine Durand, United States Addressing Inequities: Bridging the Gap for Persons Living With HIV Christine Durand, United States Addressing Inequities: Bridging the Gap for Persons Living With HIV
07:00-08:00	153	153 07:00 Invited Symposia: Can I Do That? Preventing Infection Full Details Rosy Priya Kodiyanplakkal, United States Can I Sleep With That? - PrEP for the Transplant Recipient Rosy Priya Kodiyanplakkal, United States Can I Sleep With That? - PrEP for the Transplant Recipient Ingi Lee, United States Can I Do That? Can I Prevent That? Ingi Lee, United States Can I Do That? Can I Prevent That? Jackrapong Bruminhent, Thailand Can I Travel There? Jackrapong Bruminhent, Thailand Can I Travel There?
07:00-08:00	8	8 07:00 Invited Symposia: Genetic Insights in Improving Kidney Transplant Outcomes – Practical Applications and Ethical Considerations Full Details Yasar Caliskan, United States The Future of Genetic Matching Between Kidney Donors and Recipients Yasar Caliskan, United States The Future of Genetic Matching Between Kidney Donors and Recipients Prince Anand, United States Genetic Evaluation of Living Donor Candidates: An International Review Prince Anand, United States Genetic Evaluation of Living Donor Candidates: An International Review Ebunoluwa Bamgboye, Nigeria Ethical and Practical Considerations for Genetic Testing in Kidney Transplantation: A Global Dialogue Ebunoluwa Bamgboye, Nigeria Ethical and Practical Considerations for Genetic Testing in Kidney Transplantation: A Global Dialogue
07:00-08:00	4	4 07:00 Invited Symposia: A Brave Heart and a Respite Lung - Managing Cardiac and Pulmonary Comorbidities in Non-cardiac Transplantation Full Details Aasim Afzal, United States “The Spirit Is Willing, but the Heart Is Weak”: When Is the Cardiomyopathy Prohibitive for Non-Cardiac Transplantation? Aasim Afzal, United States “The Spirit Is Willing, but the Heart Is Weak”: When Is the Cardiomyopathy Prohibitive for Non-Cardiac Transplantation? Ishna Poojary Hohman, United States “Defeating Enemies”: Managing Pulmonary Complications and Pulmonary Hypertension in Patients Undergoing Non-Cardiac Solid Organ Transplantation Ishna Poojary Hohman, United States “Defeating Enemies”: Managing Pulmonary Complications and Pulmonary Hypertension in Patients Undergoing Non-Cardiac Solid Organ Transplantation Yael Peled, Israel “Sustaining Bloodlines”: Managing Coronary Artery Disease and Valvular Disease in Patients Undergoing Non-Cardiac Transplantation Yael Peled, Israel “Sustaining Bloodlines”: Managing Coronary Artery Disease and Valvular Disease in Patients Undergoing Non-Cardiac Transplantation
07:00-08:00	12	12 07:00 Invited Symposia: HCC and Liver Transplant: Moving Beyond Milan Criteria Full Details Masatoshi Kudo, Japan Immunotherapy and HCC Management Masatoshi Kudo, Japan Immunotherapy and HCC Management Neil Mehta, United States Determining Benefit From LT in HCC and Optimizing Recipient Selection Neil Mehta, United States Determining Benefit From LT in HCC and Optimizing Recipient Selection Reena Salgia, United States Prevention and Management of Post-transplant Recurrent HCC Reena Salgia, United States Prevention and Management of Post-transplant Recurrent HCC
07:00-08:00	20	20 07:00 Rapid Fire Oral Abstract Session: Patient and Program Management Full Details Allyssa Webb, United States Extended-Release Tacrolimus Dosing in Obese Kidney Transplant Recipients Allyssa Webb, United States Extended-Release Tacrolimus Dosing in Obese Kidney Transplant Recipients Carrie Thiessen, United States Financial Need Among Solid-Organ Transplant Candidates and Recipients: Evidence from GoFundMe Crowdfunding Campaigns Carrie Thiessen, United States Financial Need Among Solid-Organ Transplant Candidates and Recipients: Evidence from GoFundMe Crowdfunding Campaigns Lisa McElroy, United States Validation of Existing Comorbidity Models and Development of a New Transplant-Specific Index Lisa McElroy, United States Validation of Existing Comorbidity Models and Development of a New Transplant-Specific Index Kelly Hsu, United States Post-Transplant Alcohol Use: Biomarker Detection, Treatment, and Outcomes Kelly Hsu, United States Post-Transplant Alcohol Use: Biomarker Detection, Treatment, and Outcomes Kyle Jennette, United States Bridging the Gap in Resource Disparities: Joint Efforts of an Academic Medical Center and a Community Safety Net Hospital to Enhance Transplant Outcomes for Underserved Communities Kyle Jennette, United States Bridging the Gap in Resource Disparities: Joint Efforts of an Academic Medical Center and a Community Safety Net Hospital to Enhance Transplant Outcomes for Underserved Communities Leana Yancey, United States Transforming Post Transplant Care: Remote Patient Monitoring for Kidney Transplant Recipients and Readmission Outcomes Leana Yancey, United States Transforming Post Transplant Care: Remote Patient Monitoring for Kidney Transplant Recipients and Readmission Outcomes Karen Khalil, United States Dosing of Pegcetacoplan with Plasmapheresis for Treatment of Xenoantibody Mediated Rejection Karen Khalil, United States Dosing of Pegcetacoplan with Plasmapheresis for Treatment of Xenoantibody Mediated Rejection Melissa McGowan, United States Long-Term Outcomes of GLP-1 Use After Liver and Simultaneous Liver Kidney Transplant Melissa McGowan, United States Long-Term Outcomes of GLP-1 Use After Liver and Simultaneous Liver Kidney Transplant
07:00-08:00	11	11 07:00 Rapid Fire Oral Abstract Session: Liver Allocation and Recipient Selection Full Details W. Ray Kim, United States MELD 3.0 - Impact on Sex Disparity One Year After Implementation W. Ray Kim, United States MELD 3.0 - Impact on Sex Disparity One Year After Implementation Bima Hasjim, United States Balancing Spontaneous Recovery and Mortality: Evaluating Model Performance in Patients with ALD Referred for Early Liver Transplantation Bima Hasjim, United States Balancing Spontaneous Recovery and Mortality: Evaluating Model Performance in Patients with ALD Referred for Early Liver Transplantation Aghnia Putri, Germany Validation of MELD 3.0 Scoring System: A Single-Center Analysis from Germany Aghnia Putri, Germany Validation of MELD 3.0 Scoring System: A Single-Center Analysis from Germany Anastasia Xynogala, United States Comparative Frailty Index Assessment in End-Stage Liver Disease Patients Undergoing Evaluation for Liver Transplant Anastasia Xynogala, United States Comparative Frailty Index Assessment in End-Stage Liver Disease Patients Undergoing Evaluation for Liver Transplant Sangeeta Satish, United States A Novel Risk Score Using Flavin Mononucleotide (FMN) for Predicting Graft Loss After Liver Transplantation with Normothermic Machine Perfusion Sangeeta Satish, United States A Novel Risk Score Using Flavin Mononucleotide (FMN) for Predicting Graft Loss After Liver Transplantation with Normothermic Machine Perfusion Laura Batista de Oliveira, United States Long-term Follow-Up in Liver Transplantation and Combined Cardiac Surgery: Validation and Refinement of the LT+CS Risk Score Using Advanced Machine Learning Laura Batista de Oliveira, United States Long-term Follow-Up in Liver Transplantation and Combined Cardiac Surgery: Validation and Refinement of the LT+CS Risk Score Using Advanced Machine Learning Daniyar Akizhanov, United States Crossing in the Air in Deceased Donor Liver Transplantation Daniyar Akizhanov, United States Crossing in the Air in Deceased Donor Liver Transplantation
07:00-08:00	10	10 07:00 Rapid Fire Oral Abstract Session: Innovative Techniques in Liver Transplantation Full Details Jaewon Lee, Korea Indocyanine Green Fluorescence Predicts Biliary Complications in Living Donor Liver Transplantation Jaewon Lee, Korea Indocyanine Green Fluorescence Predicts Biliary Complications in Living Donor Liver Transplantation Jean Botha, United States One Hundred Abdominal Normothermic Regional Perfusion (NRP) DCD Liver Transplants: Zero Ischemic Cholangiopathy Jean Botha, United States One Hundred Abdominal Normothermic Regional Perfusion (NRP) DCD Liver Transplants: Zero Ischemic Cholangiopathy Anji Wall, United States Splitting the Sandbox: The Use of Abdominal Normothermic Regional Perfusion with Super Rapid Recovery Lung Procurement Anji Wall, United States Splitting the Sandbox: The Use of Abdominal Normothermic Regional Perfusion with Super Rapid Recovery Lung Procurement Salvatore Gruttadauria, Italy Avoid the Liver Graft Recooling at the End of Normothermic Machine Perfusion: First Worldwide Experience and How I Do It Salvatore Gruttadauria, Italy Avoid the Liver Graft Recooling at the End of Normothermic Machine Perfusion: First Worldwide Experience and How I Do It Vijay Subramanian, United States Flip the Liver: Preventing Perfusion Related Liver Graft Injury in Normothermic Machine Preservation Vijay Subramanian, United States Flip the Liver: Preventing Perfusion Related Liver Graft Injury in Normothermic Machine Preservation Zachary Dietch, United States Liver Transplant Using the RAPID Technique in a Patient with Colorectal Liver Metastases Zachary Dietch, United States Liver Transplant Using the RAPID Technique in a Patient with Colorectal Liver Metastases Edward Geissler, Germany Superior Bioavailability of Tacrolimus in Liver Transplant Recipients Treated with Extended-Release LCP-Tacrolimus (Envarsus) Compared to Prolonged-Release Tacrolimus (Advagraf) After 12 Weeks of Controlled Therapy within a Multicentre, Randomised, Controlled Clinical Trial (“EnGraft”) Edward Geissler, Germany Superior Bioavailability of Tacrolimus in Liver Transplant Recipients Treated with Extended-Release LCP-Tacrolimus (Envarsus) Compared to Prolonged-Release Tacrolimus (Advagraf) After 12 Weeks of Controlled Therapy within a Multicentre, Randomised, Controlled Clinical Trial (“EnGraft”)
07:00-08:00	23	23 07:00 Rapid Fire Oral Abstract Session: All Organs: Precision Medicine, Biomarkers, and Diagnostics Full Details Minnie Sarwal, United States Precision Phenotyping Renal Transplant Dysfunction by Spatial Single-Cell Genomics Minnie Sarwal, United States Precision Phenotyping Renal Transplant Dysfunction by Spatial Single-Cell Genomics Haseeb Zubair, United States Epigenetic and Transcriptional Dynamics in Ischemia Reperfusion Injury of Liver Allografts Haseeb Zubair, United States Epigenetic and Transcriptional Dynamics in Ischemia Reperfusion Injury of Liver Allografts James Fleming, United States Association of Gene Expression Profile with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort James Fleming, United States Association of Gene Expression Profile with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort James Fleming, United States Association of Dual Noninvasive Biomarkers with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort James Fleming, United States Association of Dual Noninvasive Biomarkers with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort Weiwen Zhang, United States Identification of Anti-A2 Alloreactive Quasi-Public CD8+ T Cell Meta-Clonotypes via Bulk and Paired TCR Sequencing Weiwen Zhang, United States Identification of Anti-A2 Alloreactive Quasi-Public CD8+ T Cell Meta-Clonotypes via Bulk and Paired TCR Sequencing Minnie Sarwal, United States Impact of Maraviroc on Circulating and Tissue Markers of Kidney Transplant Recipients with HIV Minnie Sarwal, United States Impact of Maraviroc on Circulating and Tissue Markers of Kidney Transplant Recipients with HIV Minnie Sarwal, United States Epigenomic Changes in DNA Methylation State of cfDNA in Kidney Transplant Recipients with HIV Minnie Sarwal, United States Epigenomic Changes in DNA Methylation State of cfDNA in Kidney Transplant Recipients with HIV Kennedy Concannon, United States Thymo Limbo: Safety and Efficacy of Minimal-Dose Anti-Thymocyte Globulin Induction Therapy in Kidney Transplant Recipients Kennedy Concannon, United States Thymo Limbo: Safety and Efficacy of Minimal-Dose Anti-Thymocyte Globulin Induction Therapy in Kidney Transplant Recipients
07:00-08:00	154	154 07:00 Rapid Fire Oral Abstract Session: Global Pathogens, Local Impact: Fungi and Parasites Full Details Roni Bitterman, Canada Preventing Invasive Aspergillosis in Lung Transplant Recipients: A Cost-Utility Analysis Roni Bitterman, Canada Preventing Invasive Aspergillosis in Lung Transplant Recipients: A Cost-Utility Analysis Monica Fung, United States Diagnosing Coccidioidomycosis Among Solid Organ Transplant Recipients in California Monica Fung, United States Diagnosing Coccidioidomycosis Among Solid Organ Transplant Recipients in California Craig Coleman, United States Healthcare Resource Utilization, Total Healthcare Costs and Mortality in Patients with Invasive Aspergillosis and a History of Transplant Craig Coleman, United States Healthcare Resource Utilization, Total Healthcare Costs and Mortality in Patients with Invasive Aspergillosis and a History of Transplant Nicolas Barros Baertl, United States Histoplasmosis in Solid Organ Transplant Recipients: Clinical Presentation, Treatment, and Outcomes Nicolas Barros Baertl, United States Histoplasmosis in Solid Organ Transplant Recipients: Clinical Presentation, Treatment, and Outcomes Gabriel Motoa, United States Chagas Disease Reactivation and Outcomes After Solid Organ Transplantation: A Multicenter Study in the U.S. Gabriel Motoa, United States Chagas Disease Reactivation and Outcomes After Solid Organ Transplantation: A Multicenter Study in the U.S. Emily Wong, United States The Epidemiology of Endemic Fungal infections in Solid Organ Transplant Recipients: A Single-Center Study from 2010 to 2024 Emily Wong, United States The Epidemiology of Endemic Fungal infections in Solid Organ Transplant Recipients: A Single-Center Study from 2010 to 2024 Holenarasipur Vikram, United States Pneumocystis jirovecii Pneumonia in Solid Organ Transplantation: PneumoCIST Collaboration Holenarasipur Vikram, United States Pneumocystis jirovecii Pneumonia in Solid Organ Transplantation: PneumoCIST Collaboration
07:00-08:00	22	22 07:00 Rapid Fire Oral Abstract Session: Public Policy Full Details David Schladt, United States SDI Associated with Access to Kidney Transplant Even After Accounting for Insurance and Cause of End-Stage Kidney Disease David Schladt, United States SDI Associated with Access to Kidney Transplant Even After Accounting for Insurance and Cause of End-Stage Kidney Disease Hannah Roth, United States Post 5% Rule: International Travel to the United States for Liver Transplant Hannah Roth, United States Post 5% Rule: International Travel to the United States for Liver Transplant Jesse Schold, United States Annual Variability in Organ Procurement Organization Performance Tiers Jesse Schold, United States Annual Variability in Organ Procurement Organization Performance Tiers Piper Stacey, United States Imminent Death Donation: Ethical, Justified, Compassionate and Necessary Piper Stacey, United States Imminent Death Donation: Ethical, Justified, Compassionate and Necessary Chase Wehrle, United States Out of Sequence Allocation in Liver Transplants: A Poorly Used Tool to Improve Organ Utilization Chase Wehrle, United States Out of Sequence Allocation in Liver Transplants: A Poorly Used Tool to Improve Organ Utilization Jennifer Bragg-Gresham, United States Evidence to Support Accounting for the Donor Pool in OPO Performance Reports Jennifer Bragg-Gresham, United States Evidence to Support Accounting for the Donor Pool in OPO Performance Reports Jonathan Miller, United States Waitlist Mortality, Posttransplant Graft Survival, and Time Between Offers for Multiorgan Transplant Candidates in Need of a Kidney Jonathan Miller, United States Waitlist Mortality, Posttransplant Graft Survival, and Time Between Offers for Multiorgan Transplant Candidates in Need of a Kidney
07:00-08:00	9	9 07:00 Rapid Fire Oral Abstract Session: Islet Rapid Fire Full Details Srinath Chinnakotla, United States Long-Term Outcomes and Quality of Life Measures After Total Pancreatectomy and Intraportal Islet Autotransplantation in Children with Chronic Pancreatitis Srinath Chinnakotla, United States Long-Term Outcomes and Quality of Life Measures After Total Pancreatectomy and Intraportal Islet Autotransplantation in Children with Chronic Pancreatitis Michal Wszola, Poland 3D-Bioprinted Bionic Pancreas - ATMP: A Disruptive Innovation in Transplantology Michal Wszola, Poland 3D-Bioprinted Bionic Pancreas - ATMP: A Disruptive Innovation in Transplantology Kenneth Brayman, United States Microporous Annealed Particle (MAP) Gel as a Novel Scaffold for Beta-Cell Replacement Therapy: Enhancing Engraftment and Immunomodulation in a Murine Model Kenneth Brayman, United States Microporous Annealed Particle (MAP) Gel as a Novel Scaffold for Beta-Cell Replacement Therapy: Enhancing Engraftment and Immunomodulation in a Murine Model William Rust, United States SR-02, a Pancreatic Islet Replacement Therapy Transplanted to the Omentum William Rust, United States SR-02, a Pancreatic Islet Replacement Therapy Transplanted to the Omentum Nicole Wojcik, United States CD40L Co-Stimulation Blockade as a Non-Toxic Calcineurin Inhibitor-Free Immunosuppression for Beta Cell Replacement Therapy: Preliminary Results from a Pilot Clinical Study Nicole Wojcik, United States CD40L Co-Stimulation Blockade as a Non-Toxic Calcineurin Inhibitor-Free Immunosuppression for Beta Cell Replacement Therapy: Preliminary Results from a Pilot Clinical Study Argyrios Asderakis, United Kingdom The Role of microRNAs as Biomarkers of Pancreas Transplant Rejection; EMPAR Study Argyrios Asderakis, United Kingdom The Role of microRNAs as Biomarkers of Pancreas Transplant Rejection; EMPAR Study Lucas Garcias, Argentina Experience with Pancreatic Biopsies in SPK Transplantation Lucas Garcias, Argentina Experience with Pancreatic Biopsies in SPK Transplantation
08:15-09:30	9	9 08:15 Invited Symposia: The Complement System in Transplantation: Broad Consequences and Novel Treatments Full Details Dan Jane-wit, United States Endothelial Activation by Complement Dan Jane-wit, United States Endothelial Activation by Complement Hrishikesh Kulkarni, United States Dysregulated Complement Predisposes to Chronic Rejection via Adaptive Responses Hrishikesh Kulkarni, United States Dysregulated Complement Predisposes to Chronic Rejection via Adaptive Responses Carl Atkinson, United States Therapeutic Targeting of Complement in Heart and Lung Transplantation Carl Atkinson, United States Therapeutic Targeting of Complement in Heart and Lung Transplantation Ben Afzali, United States Complement as the Apex Regulator of Tissue Inflammation Ben Afzali, United States Complement as the Apex Regulator of Tissue Inflammation
08:15-09:30	154	154 08:15 Invited Symposia: Global Perspectives on Donor Pathogen Screening Full Details Alessandra Mularoni, Italy Should We Screen for HHV8 Alessandra Mularoni, Italy Should We Screen for HHV8 Cybele Lara Abad, Philippines Optimizing Donor Screening for Tuberculosis Cybele Lara Abad, Philippines Optimizing Donor Screening for Tuberculosis Hannah Nam, United States Interpreting Donor Risk for Coccidioidomycosis Hannah Nam, United States Interpreting Donor Risk for Coccidioidomycosis Helen Te, United States Considering Donors With Hepatitis B Helen Te, United States Considering Donors With Hepatitis B
08:15-09:30	4	4 08:15 Invited Symposia: Understanding and Communicating Living Kidney Donor Risk Full Details Hassan Ibrahim, United States Understanding Different Types of Risk Hassan Ibrahim, United States Understanding Different Types of Risk Kenneth Newell, United States What Are the Risks? Kenneth Newell, United States What Are the Risks? Allyson Hart, United States Shared Decision Making Allyson Hart, United States Shared Decision Making Amanda Leonberg-Yoo, United States Communicating Risk - How I Do It Amanda Leonberg-Yoo, United States Communicating Risk - How I Do It
08:15-09:30	23	23 08:15 Invited Symposia: Managing an Increasing and Increasingly Complex Patient Population Full Details Samira Farouk, United States Expanding the Workforce - Attracting New Trainees to Transplant Samira Farouk, United States Expanding the Workforce - Attracting New Trainees to Transplant John Friedewald, United States Biomarker Driven Follow-Up John Friedewald, United States Biomarker Driven Follow-Up Claudia Praglin, United States Advanced Practice Providers Claudia Praglin, United States Advanced Practice Providers Beatrice Concepcion, United States Telemedicine Beatrice Concepcion, United States Telemedicine Payaswini Vasanth, United States Working More Efficiently: Using Informatics Payaswini Vasanth, United States Working More Efficiently: Using Informatics
08:15-09:30	11	11 08:15 Invited Symposia: Pancreas Rejection: Diagnosis and Management Full Details Neeraj Singh, United States The Role of the Pancreas Biopsy, DSA, and New Biomarkers for Assessment of Pancreas Rejection Neeraj Singh, United States The Role of the Pancreas Biopsy, DSA, and New Biomarkers for Assessment of Pancreas Rejection Tarek Alhamad, United States Management of Early and Late Pancreas Rejection Tarek Alhamad, United States Management of Early and Late Pancreas Rejection Jonathan Fridell, United States The Trajectory of Progressive Pancreas Dysfunction: When Should We Consider Retransplantation? Jonathan Fridell, United States The Trajectory of Progressive Pancreas Dysfunction: When Should We Consider Retransplantation?
08:15-09:30	21	21 08:15 Invited Symposia: Perfusion Technology to Reduce Non-utilization: Lessons From Europe and Abroad Full Details Jordan Hoffman, United States The (Hidden) Costs of NRP and Machine Perfusion Jordan Hoffman, United States The (Hidden) Costs of NRP and Machine Perfusion Anji Wall, United States Using NRP to Expand DCD - Time for the US to Get on Board Anji Wall, United States Using NRP to Expand DCD - Time for the US to Get on Board Puck Groen, Netherlands Pitfalls and Promise: Opportunities to Use Sequential Perfusion Technologies Following NRP Puck Groen, Netherlands Pitfalls and Promise: Opportunities to Use Sequential Perfusion Technologies Following NRP Ajmal Zemmar, Netherlands A Neuroscientific Appraisal of DCD NRP: Policy, Practice, and Progress Ajmal Zemmar, Netherlands A Neuroscientific Appraisal of DCD NRP: Policy, Practice, and Progress
08:15-09:30	8	8 08:15 Invited Symposia: A Constructive Dialogue on Financial Neutrality - Supporting Donation and Protecting Donors Full Details Maria Matamoros, Costa Rica Financial Neutrality in Organ Donation: Defining the Boundaries Maria Matamoros, Costa Rica Financial Neutrality in Organ Donation: Defining the Boundaries Sanjay Nagral, India Financial Neutrality in an Unequal World: A View from South Asia Sanjay Nagral, India Financial Neutrality in an Unequal World: A View from South Asia Nicole Turgeon, United States AST Task Force on Financial Incentives - Updates and Scope of Work Nicole Turgeon, United States AST Task Force on Financial Incentives - Updates and Scope of Work Alexander Capron, United States A Health Justice Perspective on Financial Neutrality in Organ Donation Alexander Capron, United States A Health Justice Perspective on Financial Neutrality in Organ Donation
08:15-09:30	153	153 08:15 Invited Symposia: Virtual Crossmatch: Regulatory Updates, Long-Term Survival, and Allocation Efficiency Full Details Robert Bray, United States The Virtual Crossmatch: Principles, Applications, Regulatory Updates, Challenges and Best Practices Robert Bray, United States The Virtual Crossmatch: Principles, Applications, Regulatory Updates, Challenges and Best Practices Rajalingam Raja, United States Nine Year Outcome Analysis of Over 1,300 Consecutive Kidney Transplants Using Virtual Crossmatch Rajalingam Raja, United States Nine Year Outcome Analysis of Over 1,300 Consecutive Kidney Transplants Using Virtual Crossmatch Caner Süsal, Turkey How Does Virtual Crossmatch Improve Organ Allocation Efficiency and Geographical Sharing Caner Süsal, Turkey How Does Virtual Crossmatch Improve Organ Allocation Efficiency and Geographical Sharing
08:15-09:30	10	10 08:15 Oral Abstract: Basic Approaches on Organ Optimization Full Details Rebecca Sosa, United States Post-Translational Modifications to DAMPs Generated during Ischemia-Reperfusion Injury Drives Differential Allosensitization and Outcomes in Liver Transplant Recipients Rebecca Sosa, United States Post-Translational Modifications to DAMPs Generated during Ischemia-Reperfusion Injury Drives Differential Allosensitization and Outcomes in Liver Transplant Recipients Yong qiang Ma, People's Republic of China Mechanically Perfused P-Selectin Binding Peptide Extracellular Vesicles Alleviate Ischemia-Reperfusion Injury in Donation After Circulatory Death Liver Transplantation Yong qiang Ma, People's Republic of China Mechanically Perfused P-Selectin Binding Peptide Extracellular Vesicles Alleviate Ischemia-Reperfusion Injury in Donation After Circulatory Death Liver Transplantation Adil Bhat, United States Ischemia-Reperfusion Injury Drives Cytokine Dysregulation, Early Monocyte Activation, and Poor Outcomes in Liver Transplantation Adil Bhat, United States Ischemia-Reperfusion Injury Drives Cytokine Dysregulation, Early Monocyte Activation, and Poor Outcomes in Liver Transplantation Yong qiang Ma, People's Republic of China CCL5-Engineered Exosomes Alleviate Hepatic Ischemia-Reperfusion Injury in Donation After Circulatory Death by Targeting C1QC⁺ Macrophages via the CCR5/TGF-β Signaling Axis Yong qiang Ma, People's Republic of China CCL5-Engineered Exosomes Alleviate Hepatic Ischemia-Reperfusion Injury in Donation After Circulatory Death by Targeting C1QC⁺ Macrophages via the CCR5/TGF-β Signaling Axis Amanda Loftin, United States First Successful Preclinical Transplantations Following 72 Hours Subzero Pig Kidney Preservation with Nature-Inspired Cryoprotectants Amanda Loftin, United States First Successful Preclinical Transplantations Following 72 Hours Subzero Pig Kidney Preservation with Nature-Inspired Cryoprotectants McLean Taggart, United States Partial Frozen Enables Long-Term Preservation of the Kidney McLean Taggart, United States Partial Frozen Enables Long-Term Preservation of the Kidney Omar Alomar, United States A Novel Rodent Model of In Situ Abdominal Normothermic Regional Perfusion: Assessing Liver Injury in Marginal Steatotic Livers After Donation from Circulatory Death Omar Alomar, United States A Novel Rodent Model of In Situ Abdominal Normothermic Regional Perfusion: Assessing Liver Injury in Marginal Steatotic Livers After Donation from Circulatory Death
08:15-09:30	20	20 08:15 Oral Abstract: Deceased Donor Management Full Details Matilin Rigsby, United States Two Years of Centralizing Donation After Cardiopulmonary Death Matilin Rigsby, United States Two Years of Centralizing Donation After Cardiopulmonary Death Vishnu Potluri, United States Establishing Donor Care Units for Donation After Circulatory Death Donors: An Exploratory Analysis Using Geospatial Epidemiology Framework Vishnu Potluri, United States Establishing Donor Care Units for Donation After Circulatory Death Donors: An Exploratory Analysis Using Geospatial Epidemiology Framework Jesse Howell, United States Overdose Deaths Are Decreasing, but Donor Numbers Continue Increasing Jesse Howell, United States Overdose Deaths Are Decreasing, but Donor Numbers Continue Increasing Yuzuru Sambommatsu, United States Comparison of Back-to-Base and Upfront Normothermic Machine Perfusion in Liver Transplantation: A Retrospective Cohort Study Yuzuru Sambommatsu, United States Comparison of Back-to-Base and Upfront Normothermic Machine Perfusion in Liver Transplantation: A Retrospective Cohort Study Casey Ward, United States A Collaborative “Donor to Base” Abdominal Normothermic Regional Perfusion Program Leads to Superior Organ Utilization and Recipient Allograft Outcomes Casey Ward, United States A Collaborative “Donor to Base” Abdominal Normothermic Regional Perfusion Program Leads to Superior Organ Utilization and Recipient Allograft Outcomes Justin Hu, United States A Novel Donor Risk Index for Normothermic Machine Perfused Liver Allografts Justin Hu, United States A Novel Donor Risk Index for Normothermic Machine Perfused Liver Allografts Junpei Tarashi, United States Cradle Compression during Normothermic Machine Perfusion in Liver Transplantation: Incidence and Impact on Postoperative Outcomes Junpei Tarashi, United States Cradle Compression during Normothermic Machine Perfusion in Liver Transplantation: Incidence and Impact on Postoperative Outcomes David Reich, United States Decreased Rejection Severity with Hypothermic Oxygenated Perfusion: Sub Analysis from a Pivotal Multicenter Trial of HOPE for Liver Transplantation David Reich, United States Decreased Rejection Severity with Hypothermic Oxygenated Perfusion: Sub Analysis from a Pivotal Multicenter Trial of HOPE for Liver Transplantation
08:15-09:30	155	155 08:15 Oral Abstract: Kidney Chronic Rejection Full Details Rajalingam Raja, United States High-Affinity NK Cell IgG Receptors and De Novo DSA Are Linked to Poor Kidney Transplant Outcomes Rajalingam Raja, United States High-Affinity NK Cell IgG Receptors and De Novo DSA Are Linked to Poor Kidney Transplant Outcomes Vaka Sigurjonsdottir HLA-DQ: The Dominant Driver of De Novo Donor-Specific Antibody-Mediated Graft Failure in Pediatric Kidney Transplantation Vaka Sigurjonsdottir HLA-DQ: The Dominant Driver of De Novo Donor-Specific Antibody-Mediated Graft Failure in Pediatric Kidney Transplantation Luis Camacho Murillo, Mexico First-Line Treatment in Patients with Chronic-Active Antibody-Mediated Rejection Confers Similar Kidney Graft Survival and Post-Transplant Glomerulopathy as Patients Without Chronicity Luis Camacho Murillo, Mexico First-Line Treatment in Patients with Chronic-Active Antibody-Mediated Rejection Confers Similar Kidney Graft Survival and Post-Transplant Glomerulopathy as Patients Without Chronicity Philip Halloran, Canada Defining the Hierarchy of Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection Philip Halloran, Canada Defining the Hierarchy of Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection Ivy Rosales, United States Intra- and Extraglomerular Transcripts in Chronic Antibody Mediated Rejection Reveal Distinct Immune Responses Ivy Rosales, United States Intra- and Extraglomerular Transcripts in Chronic Antibody Mediated Rejection Reveal Distinct Immune Responses Alessia Giarraputo, France Single-Cell Spatial Transcriptomics Reveal Intraglomerular Cell Activation and Ligand-Receptor Relationships in Chronic, Active Antibody Mediated Rejection Alessia Giarraputo, France Single-Cell Spatial Transcriptomics Reveal Intraglomerular Cell Activation and Ligand-Receptor Relationships in Chronic, Active Antibody Mediated Rejection Michael Kueht, United States Comparison of a Gene Expression Profiling Panel with Combined Histopathology and Microarrays to Classify Kidney Allograft Rejection Michael Kueht, United States Comparison of a Gene Expression Profiling Panel with Combined Histopathology and Microarrays to Classify Kidney Allograft Rejection Wai Choong Lye, Singapore Anti-CD38 Monoclonal Antibody Daratumumab for the Treatment of Chronic Active-Antibody Mediated Kidney Allograft Rejection Wai Choong Lye, Singapore Anti-CD38 Monoclonal Antibody Daratumumab for the Treatment of Chronic Active-Antibody Mediated Kidney Allograft Rejection
08:15-09:30	12	12 08:15 Oral Abstract: Evolving Challenges in Transplant Oncology Full Details Cecilia Katzenstein, United States Normothermic Machine Perfusion Allows for Use of Higher Donor Risk Index Livers in Patients with Hepatocellular Carcinoma Cecilia Katzenstein, United States Normothermic Machine Perfusion Allows for Use of Higher Donor Risk Index Livers in Patients with Hepatocellular Carcinoma Chimere Ezeiruaku, United States The Effect of CD300a on the Survival of Epstein-Barr Virus (+) B Cell Lymphomas in Post-Transplant Lymphoproliferative Disorder Chimere Ezeiruaku, United States The Effect of CD300a on the Survival of Epstein-Barr Virus (+) B Cell Lymphomas in Post-Transplant Lymphoproliferative Disorder Klaus Böhler, Germany Donor-Transmitted Cancer in Organ Donation and Solid Organ Transplantation in Germany from 2016-2024 Klaus Böhler, Germany Donor-Transmitted Cancer in Organ Donation and Solid Organ Transplantation in Germany from 2016-2024 Seyed M. Hosseini-Moghaddam, Canada Machine Learning Models for Predicting Post-Transplant Lymphoproliferative Disease Risk: Insights from a Large-Scale Retrospective Cohort Study Seyed M. Hosseini-Moghaddam, Canada Machine Learning Models for Predicting Post-Transplant Lymphoproliferative Disease Risk: Insights from a Large-Scale Retrospective Cohort Study Charlotte Stephens, United Kingdom De Novo Cancer Incidence After Solid Organ Transplantation in England: The EpCOT Study Charlotte Stephens, United Kingdom De Novo Cancer Incidence After Solid Organ Transplantation in England: The EpCOT Study Qianlai Luo, United States Epidemiologic Contributions to Changing Cancer Incidence Among Solid Organ Transplant Recipients (SOTRs) in the United States Qianlai Luo, United States Epidemiologic Contributions to Changing Cancer Incidence Among Solid Organ Transplant Recipients (SOTRs) in the United States Jennifer Slota, United States Lung Transplantation in Men with High-Risk Prostate Cancer without a Mandatory Cancer-Free Period Jennifer Slota, United States Lung Transplantation in Men with High-Risk Prostate Cancer without a Mandatory Cancer-Free Period
08:15-09:30	22	22 08:15 Invited Symposia: Donor Care Units: Centralization of Donor Care, Best Practices in ICU and OR Management, Research Opportunities Full Details Clark Kensinger, United States How Centralization of Donor Care Can Lead to Increased Utilization and Better Outcomes Clark Kensinger, United States How Centralization of Donor Care Can Lead to Increased Utilization and Better Outcomes Gary Marklin, United States Emerging Best Practices for Management of the Brain Dead Donor Gary Marklin, United States Emerging Best Practices for Management of the Brain Dead Donor Philip Sommer, United States Creating Uniform Pathways for DCD Management in and out of the OR Philip Sommer, United States Creating Uniform Pathways for DCD Management in and out of the OR Emily Vail, United States The Academic Center/OPO Partnership: DCUs and Research Opportunities Emily Vail, United States The Academic Center/OPO Partnership: DCUs and Research Opportunities
08:15-09:30	25	25 08:15 Late-Breaking Oral Abstract: Allocation, Selection, and Outcomes Full Details Martha Pavlakis, United States Impact of a National Wait Time Modification Policy on Racial Inequities in Kidney Transplantation Martha Pavlakis, United States Impact of a National Wait Time Modification Policy on Racial Inequities in Kidney Transplantation Yasir Qazi, United States Outcomes Analysis of U.S. Transplant Centers Performing High Volumes of Hard to Place Kidneys; 2023-2034 Analysis. Yasir Qazi, United States Outcomes Analysis of U.S. Transplant Centers Performing High Volumes of Hard to Place Kidneys; 2023-2034 Analysis. Geoffrey Funk, United States Early Impact of a Revised Expedited Kidney Allocation Pathway on Placement Patterns and Sequence Efficiency Geoffrey Funk, United States Early Impact of a Revised Expedited Kidney Allocation Pathway on Placement Patterns and Sequence Efficiency Geoffrey Funk, United States Early Impact of a Revised Expedited Kidney Allocation Policy on the Utilization of Marginal Organs Geoffrey Funk, United States Early Impact of a Revised Expedited Kidney Allocation Policy on the Utilization of Marginal Organs Geoffrey Funk, United States No Kidney Left Behind: An Expedited Kidney Allocation Abstract Geoffrey Funk, United States No Kidney Left Behind: An Expedited Kidney Allocation Abstract Aleksandar Senev, United States Innate Allorecognition: SIRPA Locus Mismatches Between the Donor and Recipient are Associated with Kidney Allograft Survival Aleksandar Senev, United States Innate Allorecognition: SIRPA Locus Mismatches Between the Donor and Recipient are Associated with Kidney Allograft Survival Shareni Jeyamogan, United States PIRCHE, DRTC and CTLp Are Directly Correlated with HLA Mismatch and May Be Predictive of Rejection in Kidney Transplant Patients Shareni Jeyamogan, United States PIRCHE, DRTC and CTLp Are Directly Correlated with HLA Mismatch and May Be Predictive of Rejection in Kidney Transplant Patients Amirhossein Moosavi, United States Assessing Post-Transplant Outcomes in Marginal Kidney Transplants at the Center Level Amirhossein Moosavi, United States Assessing Post-Transplant Outcomes in Marginal Kidney Transplants at the Center Level
10:00-11:15	12	12 10:00 Oral Abstract: What's New in Chronic Organ Rejection Full Details Xian Li, United States Conditional Deletion of the BET Family Protein BRD4 in Macrophages Inhibits M2 Cells and Prevents Chronic Rejection Xian Li, United States Conditional Deletion of the BET Family Protein BRD4 in Macrophages Inhibits M2 Cells and Prevents Chronic Rejection Anna Peters, United States Multiome Sequencing of Chronic Ductopenic Rejection Reveals Roles for Th2 Immunity and Activated Fibroblasts in Cholangiocyte Injury Anna Peters, United States Multiome Sequencing of Chronic Ductopenic Rejection Reveals Roles for Th2 Immunity and Activated Fibroblasts in Cholangiocyte Injury Soltan Al Chaar, United States Blocking NKG2A/CD94 Interaction with Qa-1-Peptide Complex Prolongs Survival of Heart Allografts Soltan Al Chaar, United States Blocking NKG2A/CD94 Interaction with Qa-1-Peptide Complex Prolongs Survival of Heart Allografts Zijie Xu, People's Republic of China Elovl6-Mediated Fatty Acid Elongation Enhances Memory-Like NK Cell Formation Zijie Xu, People's Republic of China Elovl6-Mediated Fatty Acid Elongation Enhances Memory-Like NK Cell Formation Jaeseok Yang, Korea Suppressive Effects of Anti-Mouse and Human C4d Chimeric Antigen Receptor Regulatory T Cells on Antibody-Mediated Rejection Jaeseok Yang, Korea Suppressive Effects of Anti-Mouse and Human C4d Chimeric Antigen Receptor Regulatory T Cells on Antibody-Mediated Rejection Connor Lantz, United States CD8-Driven Cleavage of MerTK Rewires Macrophage Metabolism to Accelerate Cardiac Allograft Vasculopathy Connor Lantz, United States CD8-Driven Cleavage of MerTK Rewires Macrophage Metabolism to Accelerate Cardiac Allograft Vasculopathy Sunghae Park, Korea Preclinical Study for Evaluating the Impact of Cholangiocyte-Coated Silicone Stent on Porcine Model for Bile Leakage Sunghae Park, Korea Preclinical Study for Evaluating the Impact of Cholangiocyte-Coated Silicone Stent on Porcine Model for Bile Leakage Casey Dorr, United States Spatialomic Analysis of Kidney Biopsies Identifies Differential Abundance of Transcripts and Cell Types by Glomerular and Non-Glomerular Regions Associated with Kidney Allograft Loss Casey Dorr, United States Spatialomic Analysis of Kidney Biopsies Identifies Differential Abundance of Transcripts and Cell Types by Glomerular and Non-Glomerular Regions Associated with Kidney Allograft Loss
10:00-11:15	10	10 10:00 Oral Abstract: Advancing Organ Tolerance: Mechanisms, Strategies, and Clinical Frontiers Full Details Kenneth Dery, United States Myeloid-Hepatic Crosstalk by Human Antigen R (HuR) Regulation of CEACAM1 Improves Ischemia Tolerance in Liver Transplantation Kenneth Dery, United States Myeloid-Hepatic Crosstalk by Human Antigen R (HuR) Regulation of CEACAM1 Improves Ischemia Tolerance in Liver Transplantation Matthew Tunbridge, United States Repeated Dosing of Apoptotic Donor B Cell Infusions for Tolerance in a Non-Human Primate Model of Allogeneic Kidney Transplantation Matthew Tunbridge, United States Repeated Dosing of Apoptotic Donor B Cell Infusions for Tolerance in a Non-Human Primate Model of Allogeneic Kidney Transplantation Xiang Xiao, United States Targeting the Genomic Stability of Activated Alloreactive T Cells in the Induction of Transplant Tolerance Xiang Xiao, United States Targeting the Genomic Stability of Activated Alloreactive T Cells in the Induction of Transplant Tolerance Yaxun Huang, People's Republic of China Donor and Host Type DC Subsets in Mixed Chimeras Differentially Regulate the Development of Host-Type Peripheral Treg Cells to Promote Immune Tolerance Yaxun Huang, People's Republic of China Donor and Host Type DC Subsets in Mixed Chimeras Differentially Regulate the Development of Host-Type Peripheral Treg Cells to Promote Immune Tolerance Haval Shirwan, United States Targeted Modulation of the Fas Death Pathway Induces Tolerance to Cardiac Allograft in Mice Haval Shirwan, United States Targeted Modulation of the Fas Death Pathway Induces Tolerance to Cardiac Allograft in Mice Daniel Marconi Mendes, United States Oral Tributyrate Promotes Treg-Mediated Immune Modulation and Prolongs Allograft Survival in Murine Transplant Models Daniel Marconi Mendes, United States Oral Tributyrate Promotes Treg-Mediated Immune Modulation and Prolongs Allograft Survival in Murine Transplant Models Joseph Leventhal, United States Single Center Phase 2 and 3 Experience with Tolerance Induction in Living Donor Renal Transplant Recipients Joseph Leventhal, United States Single Center Phase 2 and 3 Experience with Tolerance Induction in Living Donor Renal Transplant Recipients Farshid Fathi, United States Evidence for Human Thymopoiesis in a Porcine Thymus Graft and T Cell Tolerance to the Source Pig in a Living Human Recipient of a Porcine Thymokidney Xenotransplant Farshid Fathi, United States Evidence for Human Thymopoiesis in a Porcine Thymus Graft and T Cell Tolerance to the Source Pig in a Living Human Recipient of a Porcine Thymokidney Xenotransplant
10:00-11:15	9	9 10:00 Oral Abstract: Infectious Risks: Bacterial Threats in Transplant Patients Full Details Brennan Collis, United States Management and Outcomes of Lung Transplant Recipients with Post-Transplant Mycobacterium Abscessus Complex Infection Brennan Collis, United States Management and Outcomes of Lung Transplant Recipients with Post-Transplant Mycobacterium Abscessus Complex Infection Andrea Cona, Italy Incidence and Clinical Impact of Carbapenem-Resistant Enterobacterales Infections in Solid Organ Transplant Recipients Andrea Cona, Italy Incidence and Clinical Impact of Carbapenem-Resistant Enterobacterales Infections in Solid Organ Transplant Recipients José Pestana, Brazil Isoniazid Prophylaxis in High-Risk Kidney Transplant Recipients: Discontinuation Rates and Active Tuberculosis Incidence José Pestana, Brazil Isoniazid Prophylaxis in High-Risk Kidney Transplant Recipients: Discontinuation Rates and Active Tuberculosis Incidence Deepali Boothankad Sharath, United States Zoonotic Infections in Solid Organ Transplant Recipients at a Single Center Deepali Boothankad Sharath, United States Zoonotic Infections in Solid Organ Transplant Recipients at a Single Center José Pestana, Brazil Sepsis-Associated Acute Kidney Injury in Kidney Transplant Recipients: Risk Factors and the Impact on Graft Function José Pestana, Brazil Sepsis-Associated Acute Kidney Injury in Kidney Transplant Recipients: Risk Factors and the Impact on Graft Function Jackrapong Bruminhent, Thailand Effectiveness of Universal Isoniazid Prophylaxis in Kidney Transplant Recipients in Tuberculosis-Endemic Regions: A Multicenter Pooled Analysis Jackrapong Bruminhent, Thailand Effectiveness of Universal Isoniazid Prophylaxis in Kidney Transplant Recipients in Tuberculosis-Endemic Regions: A Multicenter Pooled Analysis Jehanzaeb Khan, United States Infectious Complications After ERCP in Liver Transplant Recipients: Impact of MDRO and Antibiotic Use Jehanzaeb Khan, United States Infectious Complications After ERCP in Liver Transplant Recipients: Impact of MDRO and Antibiotic Use Jennifer Hu, United States Sulfonamide Antibiotic Allergy in Solid Organ Transplant: Defining the Impact and Identifying Opportunities for De-Labeling Jennifer Hu, United States Sulfonamide Antibiotic Allergy in Solid Organ Transplant: Defining the Impact and Identifying Opportunities for De-Labeling
10:00-11:15	11	11 10:00 Oral Abstract: Non-Organ Specific: Disparities in Outcome and Access to Healthcare Full Details Deirdre Sawinski, United States A Contemporary Analysis of ESRD Risk After Non-Renal Solid Organ Transplantation Deirdre Sawinski, United States A Contemporary Analysis of ESRD Risk After Non-Renal Solid Organ Transplantation Rikako Oki, United States Long-Term Conditional Graft Survival in Liver and Kidney Transplants: Does Race Matter Differently? Rikako Oki, United States Long-Term Conditional Graft Survival in Liver and Kidney Transplants: Does Race Matter Differently? Katherine Ross-Driscoll, United States A Novel Measure of Spatial Accessibility to Transplant Services Predicts Population-Based Access to Liver Transplant Katherine Ross-Driscoll, United States A Novel Measure of Spatial Accessibility to Transplant Services Predicts Population-Based Access to Liver Transplant Pallavi Kumar, India Advancing Health Equity: Public-Private Partnerships for Organ Donation and Transplantation in North-East India's Underserved Regions Pallavi Kumar, India Advancing Health Equity: Public-Private Partnerships for Organ Donation and Transplantation in North-East India's Underserved Regions Deepika Devuni, United States Pregnancy Complications Following Solid Organ Transplant Varies by Organ Type: A Multicenter Database Analysis Deepika Devuni, United States Pregnancy Complications Following Solid Organ Transplant Varies by Organ Type: A Multicenter Database Analysis Fatima Malik, United Kingdom Evolving Trends in Organ Donation and Transplantation Rates Across Muslim Majority Countries in the Last Decade Fatima Malik, United Kingdom Evolving Trends in Organ Donation and Transplantation Rates Across Muslim Majority Countries in the Last Decade Katherine Cooper, United States Cervical Dysplasia and Malignancy in Women After Solid Organ Transplant Katherine Cooper, United States Cervical Dysplasia and Malignancy in Women After Solid Organ Transplant Lama Amer, Saudi Arabia Impact of a Dedicated DM Clinic on Glycemic Control in Post-Solid Organ Transplant Patients, Lung, Liver and Kidney: A Retrospective Longitudinal Study Lama Amer, Saudi Arabia Impact of a Dedicated DM Clinic on Glycemic Control in Post-Solid Organ Transplant Patients, Lung, Liver and Kidney: A Retrospective Longitudinal Study
10:00-11:15	8	8 10:00 Oral Abstract: Liver and Kidney Transplantation Full Details Maggie Jones-Carr, United States Holes in the Safety Net: Examining Equity in Access to Kidney Transplantation for Liver Recipients under the Safety Net Policy Maggie Jones-Carr, United States Holes in the Safety Net: Examining Equity in Access to Kidney Transplantation for Liver Recipients under the Safety Net Policy Muhammad Ahmad Nadeem, United States The Impact of Normothermic Machine Perfusion in Liver Transplantation on Early Postoperative Renal Outcomes in Simultaneous Liver-Kidney Transplantation: A Propensity Score-Matched Analysis Muhammad Ahmad Nadeem, United States The Impact of Normothermic Machine Perfusion in Liver Transplantation on Early Postoperative Renal Outcomes in Simultaneous Liver-Kidney Transplantation: A Propensity Score-Matched Analysis John Montgomery, United States Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation John Montgomery, United States Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation Rikako Oki, United States The Role of Machine Perfusion in Expanding Donor Utilization for Simultaneous Liver and Kidney Transplantation Rikako Oki, United States The Role of Machine Perfusion in Expanding Donor Utilization for Simultaneous Liver and Kidney Transplantation William Werbel, United States Randomized Clinical Trial of SARS-CoV-2 Peri-Vaccination Immunosuppressive Reduction in Kidney and Liver Transplant Recipients William Werbel, United States Randomized Clinical Trial of SARS-CoV-2 Peri-Vaccination Immunosuppressive Reduction in Kidney and Liver Transplant Recipients Sarah Sheskey, United States Variation in Donation After Circulatory Death Donor Organ Yield Across Organ Procurement Organizations Sarah Sheskey, United States Variation in Donation After Circulatory Death Donor Organ Yield Across Organ Procurement Organizations Sarah Booker, United States DCD Simultaneous Liver-Kidney (SLK) Transplants in the Landscape of Expanded SLK Required Sharing Sarah Booker, United States DCD Simultaneous Liver-Kidney (SLK) Transplants in the Landscape of Expanded SLK Required Sharing Rikako Oki, United States Exploring Disease-Specific Waitlist Dynamics in Simultaneous Liver-Kidney Transplantation Rikako Oki, United States Exploring Disease-Specific Waitlist Dynamics in Simultaneous Liver-Kidney Transplantation
10:00-11:15	153	153 10:00 Oral Abstract: US Public Policy Full Details Grace Lyden, United States Exploring a New Framework for US Heart Allocation: Development of an Evidence-Based Medical Urgency Score for Adult Heart Transplant Candidates Grace Lyden, United States Exploring a New Framework for US Heart Allocation: Development of an Evidence-Based Medical Urgency Score for Adult Heart Transplant Candidates Jesse Schold, United States National IOTA Policy Will Fail to Classify Center Performance Appropriately Based on Unadjusted Models Jesse Schold, United States National IOTA Policy Will Fail to Classify Center Performance Appropriately Based on Unadjusted Models Jesse Schold, United States Evaluating the Impact of Data Source on Organ Procurement Organization Performance Metrics Jesse Schold, United States Evaluating the Impact of Data Source on Organ Procurement Organization Performance Metrics Ajay Israni, United States Developing a Tiered Survival After Listing Metric to Communicate Comparative Information About Patient Experience at Transplant Centers in the United States Ajay Israni, United States Developing a Tiered Survival After Listing Metric to Communicate Comparative Information About Patient Experience at Transplant Centers in the United States Nicholas Wood, United States Match-Run Analysis for Designing and Evaluating Allocation Policies Nicholas Wood, United States Match-Run Analysis for Designing and Evaluating Allocation Policies Gabriel Schnickel, United States Clearing the Air: The Environmental and Financial Cost of Solid Organ Transplant in the US Gabriel Schnickel, United States Clearing the Air: The Environmental and Financial Cost of Solid Organ Transplant in the US Samantha Klitenic, United States Government Investment in OPTN Infrastructure Has Been a Bargain Samantha Klitenic, United States Government Investment in OPTN Infrastructure Has Been a Bargain Alexander Capron, United States Anticipating Hurdles to Benefitting from Advanced Biopreservation of Human Organs Alexander Capron, United States Anticipating Hurdles to Benefitting from Advanced Biopreservation of Human Organs
10:00-11:15	154	154 10:00 Oral Abstract: Deceased Donor Kidney Access to Waitlist and Outcomes Full Details Luis Arias-Espinosa, United States Outcomes of High CPRA, Bypassed or Refused Offer Candidates: The Missed Chance Might Be the Last Luis Arias-Espinosa, United States Outcomes of High CPRA, Bypassed or Refused Offer Candidates: The Missed Chance Might Be the Last Hans de Ferrante, Netherlands HLA Matchability and Access to Kidney Transplantation: Disparities in Eurotransplant Hans de Ferrante, Netherlands HLA Matchability and Access to Kidney Transplantation: Disparities in Eurotransplant Jesse Schold, United States Access to HLA-DR Mismatched (MM) Deceased Donor Kidney Transplantation (DDKT) by HLA-DR Haplotype Jesse Schold, United States Access to HLA-DR Mismatched (MM) Deceased Donor Kidney Transplantation (DDKT) by HLA-DR Haplotype Bima Hasjim, United States Tale of Two Transplants: A Kidney Pair Analysis on the Impact of Social Determinants of Health Bima Hasjim, United States Tale of Two Transplants: A Kidney Pair Analysis on the Impact of Social Determinants of Health Jacob Hiss, United States Improvement in Cognition After Kidney Transplantation is Associated with Improvement in White Matter Integrity Jacob Hiss, United States Improvement in Cognition After Kidney Transplantation is Associated with Improvement in White Matter Integrity Gloria Chen, United States Barriers in Access to Transplant in the Setting of a New Transplant Program Gloria Chen, United States Barriers in Access to Transplant in the Setting of a New Transplant Program Sixto Giusti, United States Hispanic Kidney Transplant Recipients Are Significantly More Likely to Be Lost to Follow-Up Than Non-Hispanic Whites Sixto Giusti, United States Hispanic Kidney Transplant Recipients Are Significantly More Likely to Be Lost to Follow-Up Than Non-Hispanic Whites Kelli Owen, Australia How Patient Navigators Can Improve Patient Journeys for Aboriginal and Torres Strait Islander People with Kidney Disease: The COMPASS Project Kelli Owen, Australia How Patient Navigators Can Improve Patient Journeys for Aboriginal and Torres Strait Islander People with Kidney Disease: The COMPASS Project
10:00-11:15	22	22 10:00 Oral Abstract: Artificial Intelligence for Clinical Decision Making: Kidney Full Details Christie Rampersad, Canada Bias in Kidney Transplant Risk Prediction: Fairness of the Kidney Donor Risk Index and Estimated Post-Transplant Survival Score Christie Rampersad, Canada Bias in Kidney Transplant Risk Prediction: Fairness of the Kidney Donor Risk Index and Estimated Post-Transplant Survival Score Nour Asfour, United States Developing and Validating K-CRS, a Novel Medical Urgency Score for Adult Kidney Transplant Candidates Nour Asfour, United States Developing and Validating K-CRS, a Novel Medical Urgency Score for Adult Kidney Transplant Candidates Luis Gustavo Modelli de Andrade, Brazil A Data-Driven Approach to Predict Waiting Times in Kidney Transplantation Using Machine Learning Luis Gustavo Modelli de Andrade, Brazil A Data-Driven Approach to Predict Waiting Times in Kidney Transplantation Using Machine Learning Jayeon Ahn, Korea Enhanced Prediction of Recipient Renal Function Using Donor Kidney Volume and Pre-Transplant Characteristics via Machine Learning Jayeon Ahn, Korea Enhanced Prediction of Recipient Renal Function Using Donor Kidney Volume and Pre-Transplant Characteristics via Machine Learning Amy Waterman, United States Assessing Public Dialogue About Financial Concerns Related to Living Kidney Donation of Reddit Posts Using Artificial Intelligence and Qualitative Analysis Amy Waterman, United States Assessing Public Dialogue About Financial Concerns Related to Living Kidney Donation of Reddit Posts Using Artificial Intelligence and Qualitative Analysis Mark Stegall, United States Novel Artificial Intelligence-Based Measures of Inflammation Associate with Graft Loss Mark Stegall, United States Novel Artificial Intelligence-Based Measures of Inflammation Associate with Graft Loss Morgan Stuart, United States Evaluating an Open-Weight LLM for Information Extraction from Deceased Donor Renal Worksheets Morgan Stuart, United States Evaluating an Open-Weight LLM for Information Extraction from Deceased Donor Renal Worksheets Belen Rivera, United States Transparency in Kidney Transplant Recipient Selection Criteria: A Nationwide Analysis Using AI Belen Rivera, United States Transparency in Kidney Transplant Recipient Selection Criteria: A Nationwide Analysis Using AI
10:00-11:15	20	20 10:00 Oral Abstract: Living Donor Kidney Outcomes Full Details Yiting Li, United States Living Kidney Donor’s Residential Neighborhood: Driver or Barrier of Post-Transplant Follow-Up Yiting Li, United States Living Kidney Donor’s Residential Neighborhood: Driver or Barrier of Post-Transplant Follow-Up Michael Moritz, United States Living Kidney Donors Fathering a Post Transplant Pregnancy: No Impact on Graft Survival or Pregnancy Outcomes Michael Moritz, United States Living Kidney Donors Fathering a Post Transplant Pregnancy: No Impact on Graft Survival or Pregnancy Outcomes Fawaz Al Ammary, United States Long-Term Risks in Obese Living Kidney Donors: A Systematic Review and Meta-Analysis Fawaz Al Ammary, United States Long-Term Risks in Obese Living Kidney Donors: A Systematic Review and Meta-Analysis Daniel Waller, United States Postdonation Outcomes for Living Kidney Donors by Relationship to Recipient Daniel Waller, United States Postdonation Outcomes for Living Kidney Donors by Relationship to Recipient Reed Jenkins, United States Twice is Just as Nice: Favorable Donor Outcomes in Living Donor Liver Transplantation After Previous Kidney Donation Reed Jenkins, United States Twice is Just as Nice: Favorable Donor Outcomes in Living Donor Liver Transplantation After Previous Kidney Donation Abraham Matar, United States Prospective Eplet Matching in Unsensitized Recipients of Living Donor Kidneys is Associated with a Lower Incidence of De Novo DSA Abraham Matar, United States Prospective Eplet Matching in Unsensitized Recipients of Living Donor Kidneys is Associated with a Lower Incidence of De Novo DSA Daniel Del Castillo Rix, United States Impact of APOL1 Risk Variants on Post-Donation Kidney Function in Living Kidney Donors Daniel Del Castillo Rix, United States Impact of APOL1 Risk Variants on Post-Donation Kidney Function in Living Kidney Donors Carrie Thiessen, United States The Impact of Living Kidney Donor Status on the Donor-Recipient Relationship Carrie Thiessen, United States The Impact of Living Kidney Donor Status on the Donor-Recipient Relationship
10:00-11:15	23	23 10:00 Oral Abstract: Kidney, Psychosocial, Equity, and Access Full Details Joy Obayemi, United States Examining the Patient Experience of a Novel African American Transplant Access Program: A Qualitative Study Joy Obayemi, United States Examining the Patient Experience of a Novel African American Transplant Access Program: A Qualitative Study Meng Li, United States Impact of a Race-Neutral eGFR Policy on Black Kidney Transplant Candidates Meng Li, United States Impact of a Race-Neutral eGFR Policy on Black Kidney Transplant Candidates Bhavna Chopra, United States Association of Race and Ethnicity with Marginal Kidney Allocation: A Nationwide Study Bhavna Chopra, United States Association of Race and Ethnicity with Marginal Kidney Allocation: A Nationwide Study David Leeser, United States Access Inhibited by Intersecting Marginalization (AIIM) in Kidney Transplantation David Leeser, United States Access Inhibited by Intersecting Marginalization (AIIM) in Kidney Transplantation Miriam Velez-Bermudez, United States Sociocultural Factors, Racial Disparities, and Kidney Transplant Outcomes in the Kidney Transplant Fast Track (KTFT) Program Miriam Velez-Bermudez, United States Sociocultural Factors, Racial Disparities, and Kidney Transplant Outcomes in the Kidney Transplant Fast Track (KTFT) Program Meng Li, United States Impact of the Wait Time Modification Policy on Kidney Transplant Access Meng Li, United States Impact of the Wait Time Modification Policy on Kidney Transplant Access Jillian Caldwell, United States Are We There Yet? Determinants of Links Between Dialysis Units and Local Transplant Programs Jillian Caldwell, United States Are We There Yet? Determinants of Links Between Dialysis Units and Local Transplant Programs Gina Ewy, United States Preferences of Highly Sensitized People with End-Stage Kidney Disease for Proceeding with Same Day Desensitization and Transplantation or Remaining on Chronic Dialysis Gina Ewy, United States Preferences of Highly Sensitized People with End-Stage Kidney Disease for Proceeding with Same Day Desensitization and Transplantation or Remaining on Chronic Dialysis
10:00-11:15	155	155 10:00 Oral Abstract: Kidney: Novel Immunosuppressant Strategies Full Details Gillian Atkinson, United States STEADFAST Study Update: A Phase 1/2 Clinical Trial of Regulatory T Cells Expressing a Chimeric Antigen Receptor Directed Towards HLA-A2 in Renal Transplantation Gillian Atkinson, United States STEADFAST Study Update: A Phase 1/2 Clinical Trial of Regulatory T Cells Expressing a Chimeric Antigen Receptor Directed Towards HLA-A2 in Renal Transplantation Idelberto Badell, United States Every 2-Month Belatacept Maintenance Therapy in Kidney Transplant Recipients: 5-Year Follow-Up of a Randomized, Noninferiority Trial Idelberto Badell, United States Every 2-Month Belatacept Maintenance Therapy in Kidney Transplant Recipients: 5-Year Follow-Up of a Randomized, Noninferiority Trial Sandy Honda, United States Clinical Validation of a Novel Rapid Test for Point-of-Care Tacrolimus Monitoring in Kidney Transplant Recipients Sandy Honda, United States Clinical Validation of a Novel Rapid Test for Point-of-Care Tacrolimus Monitoring in Kidney Transplant Recipients Idelberto Badell, United States Late Abatacept Conversion in Kidney Transplant Recipients Receiving Belatacept: A Prospective, Randomized Controlled Noninferiority Trial Idelberto Badell, United States Late Abatacept Conversion in Kidney Transplant Recipients Receiving Belatacept: A Prospective, Randomized Controlled Noninferiority Trial Ashley Vo, United States Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up Ashley Vo, United States Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up Ali Abbasi, United States Mechanistic Insights Underlying Persistent Beneficial Impact on Kidney Function of CCR5 Blockade Following Treatment Discontinuation Ali Abbasi, United States Mechanistic Insights Underlying Persistent Beneficial Impact on Kidney Function of CCR5 Blockade Following Treatment Discontinuation Maria Meneghini, Spain Histological Reversal of Refractory ABMR with Daratumumab in Kidney Transplant Patients Maria Meneghini, Spain Histological Reversal of Refractory ABMR with Daratumumab in Kidney Transplant Patients Eliezer Katz, United States Tegoprubart, an Anti-CD40L Antibody, for the Prevention of Rejection in Kidney Transplantation: An Ongoing Phase 1B Study Eliezer Katz, United States Tegoprubart, an Anti-CD40L Antibody, for the Prevention of Rejection in Kidney Transplantation: An Ongoing Phase 1B Study
10:00-11:15	21	21 10:00 Oral Abstract: Kidney: Hot Topics 2 Full Details Giuseppe Orlando, United States Mosaic Loss of Y Chromosome in Proximal Tubular Cells is Associated with Recovery from DGF Post DCD Kidney Transplantation: A New Single Nucleus RNA-Seq Signature of Organ Quality Giuseppe Orlando, United States Mosaic Loss of Y Chromosome in Proximal Tubular Cells is Associated with Recovery from DGF Post DCD Kidney Transplantation: A New Single Nucleus RNA-Seq Signature of Organ Quality Seokwoo Park, Korea Unveiling Shared Genetic Risks of Type 2 and Post-Transplant Diabetes Mellitus in East Asians through Polygenic Risk Scores Seokwoo Park, Korea Unveiling Shared Genetic Risks of Type 2 and Post-Transplant Diabetes Mellitus in East Asians through Polygenic Risk Scores Akhil Singla, United States Cost-Effective Diagnostic Testing Models Using Four Kidney Rejection Biomarkers Akhil Singla, United States Cost-Effective Diagnostic Testing Models Using Four Kidney Rejection Biomarkers Peale Chuang, United States Renal Transplant Recipients with Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) Are at Increased Risk of Graft Loss Peale Chuang, United States Renal Transplant Recipients with Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) Are at Increased Risk of Graft Loss Jesse Schold, United States Individual and Center-Level Variation of eGFR Wait Time Modification for Black Kidney Transplant Candidates in the United States Jesse Schold, United States Individual and Center-Level Variation of eGFR Wait Time Modification for Black Kidney Transplant Candidates in the United States Joseph Kahwaji, United States Efficacy of Bariatric Surgery (BSx) versus Glucagon-Like Peptide-1 Receptor Agonists (GLP1RA) After Kidney Transplantation Joseph Kahwaji, United States Efficacy of Bariatric Surgery (BSx) versus Glucagon-Like Peptide-1 Receptor Agonists (GLP1RA) After Kidney Transplantation Jonathan Miller, United States Kidney Donor Failure Index: A Proposal for a New Way to Present Kidney Donor Risk Based on Kidney Donor Risk Index Jonathan Miller, United States Kidney Donor Failure Index: A Proposal for a New Way to Present Kidney Donor Risk Based on Kidney Donor Risk Index Yasar Caliskan, United States The Role of Genetic Testing on Kidney Transplant Evaluation and Outcomes Yasar Caliskan, United States The Role of Genetic Testing on Kidney Transplant Evaluation and Outcomes
10:00-11:15	4	4 10:00 Late-Breaking Oral Abstract: Past Meets Future: Redefining the Limits of Transplantation Full Details Nihal Aykun, United States Normothermic Machine Perfusion in Pediatric Liver Transplantation: A National and Institutional Retrospective Analysis Nihal Aykun, United States Normothermic Machine Perfusion in Pediatric Liver Transplantation: A National and Institutional Retrospective Analysis Francisco Hernandez Oliverios, Spain Hypothermic Oxygenated Perfusion (HOPE) in Pediatric Liver Transplantation: A Multicenter Study Francisco Hernandez Oliverios, Spain Hypothermic Oxygenated Perfusion (HOPE) in Pediatric Liver Transplantation: A Multicenter Study David Lee, United States Evaluation of a SUNTRAC-Based Skin Cancer Surveillance Program in Solid Organ Transplant Recipients David Lee, United States Evaluation of a SUNTRAC-Based Skin Cancer Surveillance Program in Solid Organ Transplant Recipients Nida Saleem, Australia Outcomes of Solid Organ Transplant Recipients with Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis Nida Saleem, Australia Outcomes of Solid Organ Transplant Recipients with Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis Liam Il-Young Chung, United States Double Lung Transplantation in Patients with Advanced Bilateral Lung-Limited Non-Small Cell Lung Carcinoma Liam Il-Young Chung, United States Double Lung Transplantation in Patients with Advanced Bilateral Lung-Limited Non-Small Cell Lung Carcinoma Chunrong Ju, People's Republic of China Effectiveness of Belumosudil for Chronic Lung Allograft Dysfunction after Lung Transplantation Chunrong Ju, People's Republic of China Effectiveness of Belumosudil for Chronic Lung Allograft Dysfunction after Lung Transplantation Tianhui Pan, People's Republic of China SPP1 Mediated Short-Term Epithelial-Mesenchymal Transition in Rapid Kidney Growth in Extreme Weight-Mismatched Renal Transplantation Tianhui Pan, People's Republic of China SPP1 Mediated Short-Term Epithelial-Mesenchymal Transition in Rapid Kidney Growth in Extreme Weight-Mismatched Renal Transplantation Daryl Nnani, United States Donor-Derived Cell-Free DNA-Guided Prednisone Weaning and Reduced Endomyocardial Biopsy Surveillance Following Heart Transplantation Daryl Nnani, United States Donor-Derived Cell-Free DNA-Guided Prednisone Weaning and Reduced Endomyocardial Biopsy Surveillance Following Heart Transplantation
10:00-11:15	25	25 10:00 Late-Breaking Oral Abstract: Immunosuppression and Immune Monitoring Full Details Rajalingam Raja, United States Desensitization with CD38 Monoclonal Antibody and CTLA4-Ig Enables Transplantation in Highly Sensitized Kidney Candidates with CPRA ≥99.9% Rajalingam Raja, United States Desensitization with CD38 Monoclonal Antibody and CTLA4-Ig Enables Transplantation in Highly Sensitized Kidney Candidates with CPRA ≥99.9% Nader Abraham, United States C5aR1 Inhibition Ameliorates DGF in a DCD Porcine Kidney Auto-Transplantation Model Nader Abraham, United States C5aR1 Inhibition Ameliorates DGF in a DCD Porcine Kidney Auto-Transplantation Model Zhao Feng LIU, People's Republic of China Mechanism Study of Tacrolimus Inhibiting FXR Mediated Toxicity of Renal Tubular Epithelial Cells Zhao Feng LIU, People's Republic of China Mechanism Study of Tacrolimus Inhibiting FXR Mediated Toxicity of Renal Tubular Epithelial Cells Romain Brousse, France Liquid-Biopsy Risk Assessment Versus Invasive Surveillance in Kidney Transplant: a Randomized Controlled Trial Romain Brousse, France Liquid-Biopsy Risk Assessment Versus Invasive Surveillance in Kidney Transplant: a Randomized Controlled Trial Marta Crespo, Spain First Year Pre-transplant Immunobiogram (IMBG) Predictability of de novo Rejection or Infection after 3 months in Biotraim Study Marta Crespo, Spain First Year Pre-transplant Immunobiogram (IMBG) Predictability of de novo Rejection or Infection after 3 months in Biotraim Study Ekkehard Schuetz, United States Combining Percentage and Concentration of dd-cfDNA in Kidney Transplantation is Highly Sensitive and Specific for Rejections. Results from Five Clinical Cohort Ekkehard Schuetz, United States Combining Percentage and Concentration of dd-cfDNA in Kidney Transplantation is Highly Sensitive and Specific for Rejections. Results from Five Clinical Cohort Tasha Kalista, United States Analytical and Clinical Validation of TransplantTrace cfDNA Test Tasha Kalista, United States Analytical and Clinical Validation of TransplantTrace cfDNA Test Katerina Hysi, United States Donor-derived cell-free DNA (dd-cfDNA) trends in adult kidney transplant recipients with cytomegalovirus (CMV) viremia Katerina Hysi, United States Donor-derived cell-free DNA (dd-cfDNA) trends in adult kidney transplant recipients with cytomegalovirus (CMV) viremia
11:30-12:30	Plenary	Plenary 11:30 Plenary: Closing Plenary: Reflection, Revelations, and the Road Ahead Full Details Yanik Bababekov, United States Reflections, Revelations, and the Road Ahead: Surgical Innovations Yanik Bababekov, United States Reflections, Revelations, and the Road Ahead: Surgical Innovations Dempsey Hughes, United States Reflections, Revelations, and the Road Ahead: Non-kidney Solid Organ Transplantation and Transplant Policy Dempsey Hughes, United States Reflections, Revelations, and the Road Ahead: Non-kidney Solid Organ Transplantation and Transplant Policy Ala Ali, Iraq Reflections, Revelations, and the Road Ahead: Kidney and TID Ala Ali, Iraq Reflections, Revelations, and the Road Ahead: Kidney and TID

07:00-08:00

21

07:00

Invited Symposia: Game Changers in Alloimmune Risk Stratification

Full Details

Rainer Oberbauer, Austria
Genome-Wide Non-HLA vs HLA Alloimmunity

Fadi Issa, United Kingdom
Spatial Phenotyping of Immune Cells in Tolerance Versus Rejection

Aravind Cherukuri, United States
The Impact of Innate Allorecognition

07:00-08:00

155

07:00

Invited Symposia: HIV and Transplantation: A Global Perspective on Milestones Achieved and Milestones Ahead

Full Details

Elmi Muller, South Africa
From Breakthroughs to Benchmarks: A Global History of HIV and Transplant

Vagish Hemmige, United States
Beyond the Horizon: Pioneering Thoracic and Living Donor Transplants for HIV+ Individuals

Christine Durand, United States
Addressing Inequities: Bridging the Gap for Persons Living With HIV

07:00-08:00

153

07:00

Invited Symposia: Can I Do That? Preventing Infection

Full Details

Rosy Priya Kodiyanplakkal, United States
Can I Sleep With That? - PrEP for the Transplant Recipient

Ingi Lee, United States
Can I Do That? Can I Prevent That?

Jackrapong Bruminhent, Thailand
Can I Travel There?

07:00-08:00

8

07:00

Invited Symposia: Genetic Insights in Improving Kidney Transplant Outcomes – Practical Applications and Ethical Considerations

Full Details

Yasar Caliskan, United States
The Future of Genetic Matching Between Kidney Donors and Recipients

Prince Anand, United States
Genetic Evaluation of Living Donor Candidates: An International Review

Ebunoluwa Bamgboye, Nigeria
Ethical and Practical Considerations for Genetic Testing in Kidney Transplantation: A Global Dialogue

07:00-08:00

4

07:00

Invited Symposia: A Brave Heart and a Respite Lung - Managing Cardiac and Pulmonary Comorbidities in Non-cardiac Transplantation

Full Details

Aasim Afzal, United States
“The Spirit Is Willing, but the Heart Is Weak”: When Is the Cardiomyopathy Prohibitive for Non-Cardiac Transplantation?

Ishna Poojary Hohman, United States
“Defeating Enemies”: Managing Pulmonary Complications and Pulmonary Hypertension in Patients Undergoing Non-Cardiac Solid Organ Transplantation

Yael Peled, Israel
“Sustaining Bloodlines”: Managing Coronary Artery Disease and Valvular Disease in Patients Undergoing Non-Cardiac Transplantation

07:00-08:00

12

07:00

Invited Symposia: HCC and Liver Transplant: Moving Beyond Milan Criteria

Full Details

Masatoshi Kudo, Japan
Immunotherapy and HCC Management

Neil Mehta, United States
Determining Benefit From LT in HCC and Optimizing Recipient Selection

Reena Salgia, United States
Prevention and Management of Post-transplant Recurrent HCC

07:00-08:00

20

07:00

Rapid Fire Oral Abstract Session: Patient and Program Management

Full Details

Allyssa Webb, United States
Extended-Release Tacrolimus Dosing in Obese Kidney Transplant Recipients

Carrie Thiessen, United States
Financial Need Among Solid-Organ Transplant Candidates and Recipients: Evidence from GoFundMe Crowdfunding Campaigns

Lisa McElroy, United States
Validation of Existing Comorbidity Models and Development of a New Transplant-Specific Index

Kelly Hsu, United States
Post-Transplant Alcohol Use: Biomarker Detection, Treatment, and Outcomes

Kyle Jennette, United States
Bridging the Gap in Resource Disparities: Joint Efforts of an Academic Medical Center and a Community Safety Net Hospital to Enhance Transplant Outcomes for Underserved Communities

Leana Yancey, United States
Transforming Post Transplant Care: Remote Patient Monitoring for Kidney Transplant Recipients and Readmission Outcomes

Karen Khalil, United States
Dosing of Pegcetacoplan with Plasmapheresis for Treatment of Xenoantibody Mediated Rejection

Melissa McGowan, United States
Long-Term Outcomes of GLP-1 Use After Liver and Simultaneous Liver Kidney Transplant

07:00-08:00

11

07:00

Rapid Fire Oral Abstract Session: Liver Allocation and Recipient Selection

Full Details

W. Ray Kim, United States
MELD 3.0 - Impact on Sex Disparity One Year After Implementation

Bima Hasjim, United States
Balancing Spontaneous Recovery and Mortality: Evaluating Model Performance in Patients with ALD Referred for Early Liver Transplantation

Aghnia Putri, Germany
Validation of MELD 3.0 Scoring System: A Single-Center Analysis from Germany

Anastasia Xynogala, United States
Comparative Frailty Index Assessment in End-Stage Liver Disease Patients Undergoing Evaluation for Liver Transplant

Sangeeta Satish, United States
A Novel Risk Score Using Flavin Mononucleotide (FMN) for Predicting Graft Loss After Liver Transplantation with Normothermic Machine Perfusion

Laura Batista de Oliveira, United States
Long-term Follow-Up in Liver Transplantation and Combined Cardiac Surgery: Validation and Refinement of the LT+CS Risk Score Using Advanced Machine Learning

Daniyar Akizhanov, United States
Crossing in the Air in Deceased Donor Liver Transplantation

07:00-08:00

10

07:00

Rapid Fire Oral Abstract Session: Innovative Techniques in Liver Transplantation

Full Details

Jaewon Lee, Korea
Indocyanine Green Fluorescence Predicts Biliary Complications in Living Donor Liver Transplantation

Jean Botha, United States
One Hundred Abdominal Normothermic Regional Perfusion (NRP) DCD Liver Transplants: Zero Ischemic Cholangiopathy

Anji Wall, United States
Splitting the Sandbox: The Use of Abdominal Normothermic Regional Perfusion with Super Rapid Recovery Lung Procurement

Salvatore Gruttadauria, Italy
Avoid the Liver Graft Recooling at the End of Normothermic Machine Perfusion: First Worldwide Experience and How I Do It

Vijay Subramanian, United States
Flip the Liver: Preventing Perfusion Related Liver Graft Injury in Normothermic Machine Preservation

Zachary Dietch, United States
Liver Transplant Using the RAPID Technique in a Patient with Colorectal Liver Metastases

Edward Geissler, Germany
Superior Bioavailability of Tacrolimus in Liver Transplant Recipients Treated with Extended-Release LCP-Tacrolimus (Envarsus) Compared to Prolonged-Release Tacrolimus (Advagraf) After 12 Weeks of Controlled Therapy within a Multicentre, Randomised, Controlled Clinical Trial (“EnGraft”)

07:00-08:00

23

07:00

Rapid Fire Oral Abstract Session: All Organs: Precision Medicine, Biomarkers, and Diagnostics

Full Details

Minnie Sarwal, United States
Precision Phenotyping Renal Transplant Dysfunction by Spatial Single-Cell Genomics

Haseeb Zubair, United States
Epigenetic and Transcriptional Dynamics in Ischemia Reperfusion Injury of Liver Allografts

James Fleming, United States
Association of Gene Expression Profile with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort

James Fleming, United States
Association of Dual Noninvasive Biomarkers with 10-Year All Cause Graft Loss in a Multicenter Prospective Cohort

Weiwen Zhang, United States
Identification of Anti-A2 Alloreactive Quasi-Public CD8+ T Cell Meta-Clonotypes via Bulk and Paired TCR Sequencing

Minnie Sarwal, United States
Impact of Maraviroc on Circulating and Tissue Markers of Kidney Transplant Recipients with HIV

Minnie Sarwal, United States
Epigenomic Changes in DNA Methylation State of cfDNA in Kidney Transplant Recipients with HIV

Kennedy Concannon, United States
Thymo Limbo: Safety and Efficacy of Minimal-Dose Anti-Thymocyte Globulin Induction Therapy in Kidney Transplant Recipients

07:00-08:00

154

07:00

Rapid Fire Oral Abstract Session: Global Pathogens, Local Impact: Fungi and Parasites

Full Details

Roni Bitterman, Canada
Preventing Invasive Aspergillosis in Lung Transplant Recipients: A Cost-Utility Analysis

Monica Fung, United States
Diagnosing Coccidioidomycosis Among Solid Organ Transplant Recipients in California

Craig Coleman, United States
Healthcare Resource Utilization, Total Healthcare Costs and Mortality in Patients with Invasive Aspergillosis and a History of Transplant

Nicolas Barros Baertl, United States
Histoplasmosis in Solid Organ Transplant Recipients: Clinical Presentation, Treatment, and Outcomes

Gabriel Motoa, United States
Chagas Disease Reactivation and Outcomes After Solid Organ Transplantation: A Multicenter Study in the U.S.

Emily Wong, United States
The Epidemiology of Endemic Fungal infections in Solid Organ Transplant Recipients: A Single-Center Study from 2010 to 2024

Holenarasipur Vikram, United States
Pneumocystis jirovecii Pneumonia in Solid Organ Transplantation: PneumoCIST Collaboration

07:00-08:00

22

07:00

Rapid Fire Oral Abstract Session: Public Policy

Full Details

David Schladt, United States
SDI Associated with Access to Kidney Transplant Even After Accounting for Insurance and Cause of End-Stage Kidney Disease

Hannah Roth, United States
Post 5% Rule: International Travel to the United States for Liver Transplant

Jesse Schold, United States
Annual Variability in Organ Procurement Organization Performance Tiers

Piper Stacey, United States
Imminent Death Donation: Ethical, Justified, Compassionate and Necessary

Chase Wehrle, United States
Out of Sequence Allocation in Liver Transplants: A Poorly Used Tool to Improve Organ Utilization

Jennifer Bragg-Gresham, United States
Evidence to Support Accounting for the Donor Pool in OPO Performance Reports

Jonathan Miller, United States
Waitlist Mortality, Posttransplant Graft Survival, and Time Between Offers for Multiorgan Transplant Candidates in Need of a Kidney

07:00-08:00

9

07:00

Rapid Fire Oral Abstract Session: Islet Rapid Fire

Full Details

Srinath Chinnakotla, United States
Long-Term Outcomes and Quality of Life Measures After Total Pancreatectomy and Intraportal Islet Autotransplantation in Children with Chronic Pancreatitis

Michal Wszola, Poland
3D-Bioprinted Bionic Pancreas - ATMP: A Disruptive Innovation in Transplantology

Kenneth Brayman, United States
Microporous Annealed Particle (MAP) Gel as a Novel Scaffold for Beta-Cell Replacement Therapy: Enhancing Engraftment and Immunomodulation in a Murine Model

William Rust, United States
SR-02, a Pancreatic Islet Replacement Therapy Transplanted to the Omentum

Nicole Wojcik, United States
CD40L Co-Stimulation Blockade as a Non-Toxic Calcineurin Inhibitor-Free Immunosuppression for Beta Cell Replacement Therapy: Preliminary Results from a Pilot Clinical Study

Argyrios Asderakis, United Kingdom
The Role of microRNAs as Biomarkers of Pancreas Transplant Rejection; EMPAR Study

Lucas Garcias, Argentina
Experience with Pancreatic Biopsies in SPK Transplantation

08:15-09:30

9

08:15

Invited Symposia: The Complement System in Transplantation: Broad Consequences and Novel Treatments

Full Details

Dan Jane-wit, United States
Endothelial Activation by Complement

Hrishikesh Kulkarni, United States
Dysregulated Complement Predisposes to Chronic Rejection via Adaptive Responses

Carl Atkinson, United States
Therapeutic Targeting of Complement in Heart and Lung Transplantation

Ben Afzali, United States
Complement as the Apex Regulator of Tissue Inflammation

08:15-09:30

154

08:15

Invited Symposia: Global Perspectives on Donor Pathogen Screening

Full Details

Alessandra Mularoni, Italy
Should We Screen for HHV8

Cybele Lara Abad, Philippines
Optimizing Donor Screening for Tuberculosis

Hannah Nam, United States
Interpreting Donor Risk for Coccidioidomycosis

Helen Te, United States
Considering Donors With Hepatitis B

08:15-09:30

4

08:15

Invited Symposia: Understanding and Communicating Living Kidney Donor Risk

Full Details

Hassan Ibrahim, United States
Understanding Different Types of Risk

Kenneth Newell, United States
What Are the Risks?

Allyson Hart, United States
Shared Decision Making

Amanda Leonberg-Yoo, United States
Communicating Risk - How I Do It

08:15-09:30

23

08:15

Invited Symposia: Managing an Increasing and Increasingly Complex Patient Population

Full Details

Samira Farouk, United States
Expanding the Workforce - Attracting New Trainees to Transplant

John Friedewald, United States
Biomarker Driven Follow-Up

Claudia Praglin, United States
Advanced Practice Providers

Beatrice Concepcion, United States
Telemedicine

Payaswini Vasanth, United States
Working More Efficiently: Using Informatics

08:15-09:30

11

08:15

Invited Symposia: Pancreas Rejection: Diagnosis and Management

Full Details

Neeraj Singh, United States
The Role of the Pancreas Biopsy, DSA, and New Biomarkers for Assessment of Pancreas Rejection

Tarek Alhamad, United States
Management of Early and Late Pancreas Rejection

Jonathan Fridell, United States
The Trajectory of Progressive Pancreas Dysfunction: When Should We Consider Retransplantation?

08:15-09:30

21

08:15

Invited Symposia: Perfusion Technology to Reduce Non-utilization: Lessons From Europe and Abroad

Full Details

Jordan Hoffman, United States
The (Hidden) Costs of NRP and Machine Perfusion

Anji Wall, United States
Using NRP to Expand DCD - Time for the US to Get on Board

Puck Groen, Netherlands
Pitfalls and Promise: Opportunities to Use Sequential Perfusion Technologies Following NRP

Ajmal Zemmar, Netherlands
A Neuroscientific Appraisal of DCD NRP: Policy, Practice, and Progress

08:15-09:30

8

08:15

Invited Symposia: A Constructive Dialogue on Financial Neutrality - Supporting Donation and Protecting Donors

Full Details

Maria Matamoros, Costa Rica
Financial Neutrality in Organ Donation: Defining the Boundaries

Sanjay Nagral, India
Financial Neutrality in an Unequal World: A View from South Asia

Nicole Turgeon, United States
AST Task Force on Financial Incentives - Updates and Scope of Work

Alexander Capron, United States
A Health Justice Perspective on Financial Neutrality in Organ Donation

08:15-09:30

153

08:15

Invited Symposia: Virtual Crossmatch: Regulatory Updates, Long-Term Survival, and Allocation Efficiency

Full Details

Robert Bray, United States
The Virtual Crossmatch: Principles, Applications, Regulatory Updates, Challenges and Best Practices

Rajalingam Raja, United States
Nine Year Outcome Analysis of Over 1,300 Consecutive Kidney Transplants Using Virtual Crossmatch

Caner Süsal, Turkey
How Does Virtual Crossmatch Improve Organ Allocation Efficiency and Geographical Sharing

08:15-09:30

10

08:15

Oral Abstract: Basic Approaches on Organ Optimization

Full Details

Rebecca Sosa, United States
Post-Translational Modifications to DAMPs Generated during Ischemia-Reperfusion Injury Drives Differential Allosensitization and Outcomes in Liver Transplant Recipients

Yong qiang Ma, People's Republic of China
Mechanically Perfused P-Selectin Binding Peptide Extracellular Vesicles Alleviate Ischemia-Reperfusion Injury in Donation After Circulatory Death Liver Transplantation

Adil Bhat, United States
Ischemia-Reperfusion Injury Drives Cytokine Dysregulation, Early Monocyte Activation, and Poor Outcomes in Liver Transplantation

Yong qiang Ma, People's Republic of China
CCL5-Engineered Exosomes Alleviate Hepatic Ischemia-Reperfusion Injury in Donation After Circulatory Death by Targeting C1QC⁺ Macrophages via the CCR5/TGF-β Signaling Axis

Amanda Loftin, United States
First Successful Preclinical Transplantations Following 72 Hours Subzero Pig Kidney Preservation with Nature-Inspired Cryoprotectants

McLean Taggart, United States
Partial Frozen Enables Long-Term Preservation of the Kidney

Omar Alomar, United States
A Novel Rodent Model of In Situ Abdominal Normothermic Regional Perfusion: Assessing Liver Injury in Marginal Steatotic Livers After Donation from Circulatory Death

08:15-09:30

20

08:15

Oral Abstract: Deceased Donor Management

Full Details

Matilin Rigsby, United States
Two Years of Centralizing Donation After Cardiopulmonary Death

Vishnu Potluri, United States
Establishing Donor Care Units for Donation After Circulatory Death Donors: An Exploratory Analysis Using Geospatial Epidemiology Framework

Jesse Howell, United States
Overdose Deaths Are Decreasing, but Donor Numbers Continue Increasing

Yuzuru Sambommatsu, United States
Comparison of Back-to-Base and Upfront Normothermic Machine Perfusion in Liver Transplantation: A Retrospective Cohort Study

Casey Ward, United States
A Collaborative “Donor to Base” Abdominal Normothermic Regional Perfusion Program Leads to Superior Organ Utilization and Recipient Allograft Outcomes

Justin Hu, United States
A Novel Donor Risk Index for Normothermic Machine Perfused Liver Allografts

Junpei Tarashi, United States
Cradle Compression during Normothermic Machine Perfusion in Liver Transplantation: Incidence and Impact on Postoperative Outcomes

David Reich, United States
Decreased Rejection Severity with Hypothermic Oxygenated Perfusion: Sub Analysis from a Pivotal Multicenter Trial of HOPE for Liver Transplantation

08:15-09:30

155

08:15

Oral Abstract: Kidney Chronic Rejection

Full Details

Rajalingam Raja, United States
High-Affinity NK Cell IgG Receptors and De Novo DSA Are Linked to Poor Kidney Transplant Outcomes

Vaka Sigurjonsdottir
HLA-DQ: The Dominant Driver of De Novo Donor-Specific Antibody-Mediated Graft Failure in Pediatric Kidney Transplantation

Luis Camacho Murillo, Mexico
First-Line Treatment in Patients with Chronic-Active Antibody-Mediated Rejection Confers Similar Kidney Graft Survival and Post-Transplant Glomerulopathy as Patients Without Chronicity

Philip Halloran, Canada
Defining the Hierarchy of Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection

Ivy Rosales, United States
Intra- and Extraglomerular Transcripts in Chronic Antibody Mediated Rejection Reveal Distinct Immune Responses

Alessia Giarraputo, France
Single-Cell Spatial Transcriptomics Reveal Intraglomerular Cell Activation and Ligand-Receptor Relationships in Chronic, Active Antibody Mediated Rejection

Michael Kueht, United States
Comparison of a Gene Expression Profiling Panel with Combined Histopathology and Microarrays to Classify Kidney Allograft Rejection

Wai Choong Lye, Singapore
Anti-CD38 Monoclonal Antibody Daratumumab for the Treatment of Chronic Active-Antibody Mediated Kidney Allograft Rejection

08:15-09:30

12

08:15

Oral Abstract: Evolving Challenges in Transplant Oncology

Full Details

Cecilia Katzenstein, United States
Normothermic Machine Perfusion Allows for Use of Higher Donor Risk Index Livers in Patients with Hepatocellular Carcinoma

Chimere Ezeiruaku, United States
The Effect of CD300a on the Survival of Epstein-Barr Virus (+) B Cell Lymphomas in Post-Transplant Lymphoproliferative Disorder

Klaus Böhler, Germany
Donor-Transmitted Cancer in Organ Donation and Solid Organ Transplantation in Germany from 2016-2024

Seyed M. Hosseini-Moghaddam, Canada
Machine Learning Models for Predicting Post-Transplant Lymphoproliferative Disease Risk: Insights from a Large-Scale Retrospective Cohort Study

Charlotte Stephens, United Kingdom
De Novo Cancer Incidence After Solid Organ Transplantation in England: The EpCOT Study

Qianlai Luo, United States
Epidemiologic Contributions to Changing Cancer Incidence Among Solid Organ Transplant Recipients (SOTRs) in the United States

Jennifer Slota, United States
Lung Transplantation in Men with High-Risk Prostate Cancer without a Mandatory Cancer-Free Period

08:15-09:30

22

08:15

Invited Symposia: Donor Care Units: Centralization of Donor Care, Best Practices in ICU and OR Management, Research Opportunities

Full Details

Clark Kensinger, United States
How Centralization of Donor Care Can Lead to Increased Utilization and Better Outcomes

Gary Marklin, United States
Emerging Best Practices for Management of the Brain Dead Donor

Philip Sommer, United States
Creating Uniform Pathways for DCD Management in and out of the OR

Emily Vail, United States
The Academic Center/OPO Partnership: DCUs and Research Opportunities

08:15-09:30

25

08:15

Late-Breaking Oral Abstract: Allocation, Selection, and Outcomes

Full Details

Martha Pavlakis, United States
Impact of a National Wait Time Modification Policy on Racial Inequities in Kidney Transplantation

Yasir Qazi, United States
Outcomes Analysis of U.S. Transplant Centers Performing High Volumes of Hard to Place Kidneys; 2023-2034 Analysis.

Geoffrey Funk, United States
Early Impact of a Revised Expedited Kidney Allocation Pathway on Placement Patterns and Sequence Efficiency

Geoffrey Funk, United States
Early Impact of a Revised Expedited Kidney Allocation Policy on the Utilization of Marginal Organs

Geoffrey Funk, United States
No Kidney Left Behind: An Expedited Kidney Allocation Abstract

Aleksandar Senev, United States
Innate Allorecognition: SIRPA Locus Mismatches Between the Donor and Recipient are Associated with Kidney Allograft Survival

Shareni Jeyamogan, United States
PIRCHE, DRTC and CTLp Are Directly Correlated with HLA Mismatch and May Be Predictive of Rejection in Kidney Transplant Patients

Amirhossein Moosavi, United States
Assessing Post-Transplant Outcomes in Marginal Kidney Transplants at the Center Level

10:00-11:15

12

10:00

Oral Abstract: What's New in Chronic Organ Rejection

Full Details

Xian Li, United States
Conditional Deletion of the BET Family Protein BRD4 in Macrophages Inhibits M2 Cells and Prevents Chronic Rejection

Anna Peters, United States
Multiome Sequencing of Chronic Ductopenic Rejection Reveals Roles for Th2 Immunity and Activated Fibroblasts in Cholangiocyte Injury

Soltan Al Chaar, United States
Blocking NKG2A/CD94 Interaction with Qa-1-Peptide Complex Prolongs Survival of Heart Allografts

Zijie Xu, People's Republic of China
Elovl6-Mediated Fatty Acid Elongation Enhances Memory-Like NK Cell Formation

Jaeseok Yang, Korea
Suppressive Effects of Anti-Mouse and Human C4d Chimeric Antigen Receptor Regulatory T Cells on Antibody-Mediated Rejection

Connor Lantz, United States
CD8-Driven Cleavage of MerTK Rewires Macrophage Metabolism to Accelerate Cardiac Allograft Vasculopathy

Sunghae Park, Korea
Preclinical Study for Evaluating the Impact of Cholangiocyte-Coated Silicone Stent on Porcine Model for Bile Leakage

Casey Dorr, United States
Spatialomic Analysis of Kidney Biopsies Identifies Differential Abundance of Transcripts and Cell Types by Glomerular and Non-Glomerular Regions Associated with Kidney Allograft Loss

10:00-11:15

10

10:00

Oral Abstract: Advancing Organ Tolerance: Mechanisms, Strategies, and Clinical Frontiers

Full Details

Kenneth Dery, United States
Myeloid-Hepatic Crosstalk by Human Antigen R (HuR) Regulation of CEACAM1 Improves Ischemia Tolerance in Liver Transplantation

Matthew Tunbridge, United States
Repeated Dosing of Apoptotic Donor B Cell Infusions for Tolerance in a Non-Human Primate Model of Allogeneic Kidney Transplantation

Xiang Xiao, United States
Targeting the Genomic Stability of Activated Alloreactive T Cells in the Induction of Transplant Tolerance

Yaxun Huang, People's Republic of China
Donor and Host Type DC Subsets in Mixed Chimeras Differentially Regulate the Development of Host-Type Peripheral Treg Cells to Promote Immune Tolerance

Haval Shirwan, United States
Targeted Modulation of the Fas Death Pathway Induces Tolerance to Cardiac Allograft in Mice

Daniel Marconi Mendes, United States
Oral Tributyrate Promotes Treg-Mediated Immune Modulation and Prolongs Allograft Survival in Murine Transplant Models

Joseph Leventhal, United States
Single Center Phase 2 and 3 Experience with Tolerance Induction in Living Donor Renal Transplant Recipients

Farshid Fathi, United States
Evidence for Human Thymopoiesis in a Porcine Thymus Graft and T Cell Tolerance to the Source Pig in a Living Human Recipient of a Porcine Thymokidney Xenotransplant

10:00-11:15

9

10:00

Oral Abstract: Infectious Risks: Bacterial Threats in Transplant Patients

Full Details

Brennan Collis, United States
Management and Outcomes of Lung Transplant Recipients with Post-Transplant Mycobacterium Abscessus Complex Infection

Andrea Cona, Italy
Incidence and Clinical Impact of Carbapenem-Resistant Enterobacterales Infections in Solid Organ Transplant Recipients

José Pestana, Brazil
Isoniazid Prophylaxis in High-Risk Kidney Transplant Recipients: Discontinuation Rates and Active Tuberculosis Incidence

Deepali Boothankad Sharath, United States
Zoonotic Infections in Solid Organ Transplant Recipients at a Single Center

José Pestana, Brazil
Sepsis-Associated Acute Kidney Injury in Kidney Transplant Recipients: Risk Factors and the Impact on Graft Function

Jackrapong Bruminhent, Thailand
Effectiveness of Universal Isoniazid Prophylaxis in Kidney Transplant Recipients in Tuberculosis-Endemic Regions: A Multicenter Pooled Analysis

Jehanzaeb Khan, United States
Infectious Complications After ERCP in Liver Transplant Recipients: Impact of MDRO and Antibiotic Use

Jennifer Hu, United States
Sulfonamide Antibiotic Allergy in Solid Organ Transplant: Defining the Impact and Identifying Opportunities for De-Labeling

10:00-11:15

11

10:00

Oral Abstract: Non-Organ Specific: Disparities in Outcome and Access to Healthcare

Full Details

Deirdre Sawinski, United States
A Contemporary Analysis of ESRD Risk After Non-Renal Solid Organ Transplantation

Rikako Oki, United States
Long-Term Conditional Graft Survival in Liver and Kidney Transplants: Does Race Matter Differently?

Katherine Ross-Driscoll, United States
A Novel Measure of Spatial Accessibility to Transplant Services Predicts Population-Based Access to Liver Transplant

Pallavi Kumar, India
Advancing Health Equity: Public-Private Partnerships for Organ Donation and Transplantation in North-East India's Underserved Regions

Deepika Devuni, United States
Pregnancy Complications Following Solid Organ Transplant Varies by Organ Type: A Multicenter Database Analysis

Fatima Malik, United Kingdom
Evolving Trends in Organ Donation and Transplantation Rates Across Muslim Majority Countries in the Last Decade

Katherine Cooper, United States
Cervical Dysplasia and Malignancy in Women After Solid Organ Transplant

Lama Amer, Saudi Arabia
Impact of a Dedicated DM Clinic on Glycemic Control in Post-Solid Organ Transplant Patients, Lung, Liver and Kidney: A Retrospective Longitudinal Study

10:00-11:15

8

10:00

Oral Abstract: Liver and Kidney Transplantation

Full Details

Maggie Jones-Carr, United States
Holes in the Safety Net: Examining Equity in Access to Kidney Transplantation for Liver Recipients under the Safety Net Policy

Muhammad Ahmad Nadeem, United States
The Impact of Normothermic Machine Perfusion in Liver Transplantation on Early Postoperative Renal Outcomes in Simultaneous Liver-Kidney Transplantation: A Propensity Score-Matched Analysis

John Montgomery, United States
Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation

Rikako Oki, United States
The Role of Machine Perfusion in Expanding Donor Utilization for Simultaneous Liver and Kidney Transplantation

William Werbel, United States
Randomized Clinical Trial of SARS-CoV-2 Peri-Vaccination Immunosuppressive Reduction in Kidney and Liver Transplant Recipients

Sarah Sheskey, United States
Variation in Donation After Circulatory Death Donor Organ Yield Across Organ Procurement Organizations

Sarah Booker, United States
DCD Simultaneous Liver-Kidney (SLK) Transplants in the Landscape of Expanded SLK Required Sharing

Rikako Oki, United States
Exploring Disease-Specific Waitlist Dynamics in Simultaneous Liver-Kidney Transplantation

10:00-11:15

153

10:00

Oral Abstract: US Public Policy

Full Details

Grace Lyden, United States
Exploring a New Framework for US Heart Allocation: Development of an Evidence-Based Medical Urgency Score for Adult Heart Transplant Candidates

Jesse Schold, United States
National IOTA Policy Will Fail to Classify Center Performance Appropriately Based on Unadjusted Models

Jesse Schold, United States
Evaluating the Impact of Data Source on Organ Procurement Organization Performance Metrics

Ajay Israni, United States
Developing a Tiered Survival After Listing Metric to Communicate Comparative Information About Patient Experience at Transplant Centers in the United States

Nicholas Wood, United States
Match-Run Analysis for Designing and Evaluating Allocation Policies

Gabriel Schnickel, United States
Clearing the Air: The Environmental and Financial Cost of Solid Organ Transplant in the US

Samantha Klitenic, United States
Government Investment in OPTN Infrastructure Has Been a Bargain

Alexander Capron, United States
Anticipating Hurdles to Benefitting from Advanced Biopreservation of Human Organs

10:00-11:15

154

10:00

Oral Abstract: Deceased Donor Kidney Access to Waitlist and Outcomes

Full Details

Luis Arias-Espinosa, United States
Outcomes of High CPRA, Bypassed or Refused Offer Candidates: The Missed Chance Might Be the Last

Hans de Ferrante, Netherlands
HLA Matchability and Access to Kidney Transplantation: Disparities in Eurotransplant

Jesse Schold, United States
Access to HLA-DR Mismatched (MM) Deceased Donor Kidney Transplantation (DDKT) by HLA-DR Haplotype

Bima Hasjim, United States
Tale of Two Transplants: A Kidney Pair Analysis on the Impact of Social Determinants of Health

Jacob Hiss, United States
Improvement in Cognition After Kidney Transplantation is Associated with Improvement in White Matter Integrity

Gloria Chen, United States
Barriers in Access to Transplant in the Setting of a New Transplant Program

Sixto Giusti, United States
Hispanic Kidney Transplant Recipients Are Significantly More Likely to Be Lost to Follow-Up Than Non-Hispanic Whites

Kelli Owen, Australia
How Patient Navigators Can Improve Patient Journeys for Aboriginal and Torres Strait Islander People with Kidney Disease: The COMPASS Project

10:00-11:15

22

10:00

Oral Abstract: Artificial Intelligence for Clinical Decision Making: Kidney

Full Details

Christie Rampersad, Canada
Bias in Kidney Transplant Risk Prediction: Fairness of the Kidney Donor Risk Index and Estimated Post-Transplant Survival Score

Nour Asfour, United States
Developing and Validating K-CRS, a Novel Medical Urgency Score for Adult Kidney Transplant Candidates

Luis Gustavo Modelli de Andrade, Brazil
A Data-Driven Approach to Predict Waiting Times in Kidney Transplantation Using Machine Learning

Jayeon Ahn, Korea
Enhanced Prediction of Recipient Renal Function Using Donor Kidney Volume and Pre-Transplant Characteristics via Machine Learning

Amy Waterman, United States
Assessing Public Dialogue About Financial Concerns Related to Living Kidney Donation of Reddit Posts Using Artificial Intelligence and Qualitative Analysis

Mark Stegall, United States
Novel Artificial Intelligence-Based Measures of Inflammation Associate with Graft Loss

Morgan Stuart, United States
Evaluating an Open-Weight LLM for Information Extraction from Deceased Donor Renal Worksheets

Belen Rivera, United States
Transparency in Kidney Transplant Recipient Selection Criteria: A Nationwide Analysis Using AI

10:00-11:15

20

10:00

Oral Abstract: Living Donor Kidney Outcomes

Full Details

Yiting Li, United States
Living Kidney Donor’s Residential Neighborhood: Driver or Barrier of Post-Transplant Follow-Up

Michael Moritz, United States
Living Kidney Donors Fathering a Post Transplant Pregnancy: No Impact on Graft Survival or Pregnancy Outcomes

Fawaz Al Ammary, United States
Long-Term Risks in Obese Living Kidney Donors: A Systematic Review and Meta-Analysis

Daniel Waller, United States
Postdonation Outcomes for Living Kidney Donors by Relationship to Recipient

Reed Jenkins, United States
Twice is Just as Nice: Favorable Donor Outcomes in Living Donor Liver Transplantation After Previous Kidney Donation

Abraham Matar, United States
Prospective Eplet Matching in Unsensitized Recipients of Living Donor Kidneys is Associated with a Lower Incidence of De Novo DSA

Daniel Del Castillo Rix, United States
Impact of APOL1 Risk Variants on Post-Donation Kidney Function in Living Kidney Donors

Carrie Thiessen, United States
The Impact of Living Kidney Donor Status on the Donor-Recipient Relationship

10:00-11:15

23

10:00

Oral Abstract: Kidney, Psychosocial, Equity, and Access

Full Details

Joy Obayemi, United States
Examining the Patient Experience of a Novel African American Transplant Access Program: A Qualitative Study

Meng Li, United States
Impact of a Race-Neutral eGFR Policy on Black Kidney Transplant Candidates

Bhavna Chopra, United States
Association of Race and Ethnicity with Marginal Kidney Allocation: A Nationwide Study

David Leeser, United States
Access Inhibited by Intersecting Marginalization (AIIM) in Kidney Transplantation

Miriam Velez-Bermudez, United States
Sociocultural Factors, Racial Disparities, and Kidney Transplant Outcomes in the Kidney Transplant Fast Track (KTFT) Program

Meng Li, United States
Impact of the Wait Time Modification Policy on Kidney Transplant Access

Jillian Caldwell, United States
Are We There Yet? Determinants of Links Between Dialysis Units and Local Transplant Programs

Gina Ewy, United States
Preferences of Highly Sensitized People with End-Stage Kidney Disease for Proceeding with Same Day Desensitization and Transplantation or Remaining on Chronic Dialysis

10:00-11:15

155

10:00

Oral Abstract: Kidney: Novel Immunosuppressant Strategies

Full Details

Gillian Atkinson, United States
STEADFAST Study Update: A Phase 1/2 Clinical Trial of Regulatory T Cells Expressing a Chimeric Antigen Receptor Directed Towards HLA-A2 in Renal Transplantation

Idelberto Badell, United States
Every 2-Month Belatacept Maintenance Therapy in Kidney Transplant Recipients: 5-Year Follow-Up of a Randomized, Noninferiority Trial

Sandy Honda, United States
Clinical Validation of a Novel Rapid Test for Point-of-Care Tacrolimus Monitoring in Kidney Transplant Recipients

Idelberto Badell, United States
Late Abatacept Conversion in Kidney Transplant Recipients Receiving Belatacept: A Prospective, Randomized Controlled Noninferiority Trial

Ashley Vo, United States
Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up

Ali Abbasi, United States
Mechanistic Insights Underlying Persistent Beneficial Impact on Kidney Function of CCR5 Blockade Following Treatment Discontinuation

Maria Meneghini, Spain
Histological Reversal of Refractory ABMR with Daratumumab in Kidney Transplant Patients

Eliezer Katz, United States
Tegoprubart, an Anti-CD40L Antibody, for the Prevention of Rejection in Kidney Transplantation: An Ongoing Phase 1B Study

10:00-11:15

21

10:00

Oral Abstract: Kidney: Hot Topics 2

Full Details

Giuseppe Orlando, United States
Mosaic Loss of Y Chromosome in Proximal Tubular Cells is Associated with Recovery from DGF Post DCD Kidney Transplantation: A New Single Nucleus RNA-Seq Signature of Organ Quality

Seokwoo Park, Korea
Unveiling Shared Genetic Risks of Type 2 and Post-Transplant Diabetes Mellitus in East Asians through Polygenic Risk Scores

Akhil Singla, United States
Cost-Effective Diagnostic Testing Models Using Four Kidney Rejection Biomarkers

Peale Chuang, United States
Renal Transplant Recipients with Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) Are at Increased Risk of Graft Loss

Jesse Schold, United States
Individual and Center-Level Variation of eGFR Wait Time Modification for Black Kidney Transplant Candidates in the United States

Joseph Kahwaji, United States
Efficacy of Bariatric Surgery (BSx) versus Glucagon-Like Peptide-1 Receptor Agonists (GLP1RA) After Kidney Transplantation

Jonathan Miller, United States
Kidney Donor Failure Index: A Proposal for a New Way to Present Kidney Donor Risk Based on Kidney Donor Risk Index

Yasar Caliskan, United States
The Role of Genetic Testing on Kidney Transplant Evaluation and Outcomes

10:00-11:15

4

10:00

Late-Breaking Oral Abstract: Past Meets Future: Redefining the Limits of Transplantation

Full Details

Nihal Aykun, United States
Normothermic Machine Perfusion in Pediatric Liver Transplantation: A National and Institutional Retrospective Analysis

Francisco Hernandez Oliverios, Spain
Hypothermic Oxygenated Perfusion (HOPE) in Pediatric Liver Transplantation: A Multicenter Study

David Lee, United States
Evaluation of a SUNTRAC-Based Skin Cancer Surveillance Program in Solid Organ Transplant Recipients

Nida Saleem, Australia
Outcomes of Solid Organ Transplant Recipients with Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis

Liam Il-Young Chung, United States
Double Lung Transplantation in Patients with Advanced Bilateral Lung-Limited Non-Small Cell Lung Carcinoma

Chunrong Ju, People's Republic of China
Effectiveness of Belumosudil for Chronic Lung Allograft Dysfunction after Lung Transplantation

Tianhui Pan, People's Republic of China
SPP1 Mediated Short-Term Epithelial-Mesenchymal Transition in Rapid Kidney Growth in Extreme Weight-Mismatched Renal Transplantation

Daryl Nnani, United States
Donor-Derived Cell-Free DNA-Guided Prednisone Weaning and Reduced Endomyocardial Biopsy Surveillance Following Heart Transplantation

10:00-11:15

25

10:00

Late-Breaking Oral Abstract: Immunosuppression and Immune Monitoring

Full Details

Rajalingam Raja, United States
Desensitization with CD38 Monoclonal Antibody and CTLA4-Ig Enables Transplantation in Highly Sensitized Kidney Candidates with CPRA ≥99.9%

Nader Abraham, United States
C5aR1 Inhibition Ameliorates DGF in a DCD Porcine Kidney Auto-Transplantation Model

Zhao Feng LIU, People's Republic of China
Mechanism Study of Tacrolimus Inhibiting FXR Mediated Toxicity of Renal Tubular Epithelial Cells

Romain Brousse, France
Liquid-Biopsy Risk Assessment Versus Invasive Surveillance in Kidney Transplant: a Randomized Controlled Trial

Marta Crespo, Spain
First Year Pre-transplant Immunobiogram (IMBG) Predictability of de novo Rejection or Infection after 3 months in Biotraim Study

Ekkehard Schuetz, United States
Combining Percentage and Concentration of dd-cfDNA in Kidney Transplantation is Highly Sensitive and Specific for Rejections. Results from Five Clinical Cohort

Tasha Kalista, United States
Analytical and Clinical Validation of TransplantTrace cfDNA Test

Katerina Hysi, United States
Donor-derived cell-free DNA (dd-cfDNA) trends in adult kidney transplant recipients with cytomegalovirus (CMV) viremia

11:30-12:30

Plenary

11:30

Plenary: Closing Plenary: Reflection, Revelations, and the Road Ahead

Full Details

Yanik Bababekov, United States
Reflections, Revelations, and the Road Ahead: Surgical Innovations

Dempsey Hughes, United States
Reflections, Revelations, and the Road Ahead: Non-kidney Solid Organ Transplantation and Transplant Policy

Ala Ali, Iraq
Reflections, Revelations, and the Road Ahead: Kidney and TID